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Abstract
Sluggish cognitive tempo (SCT) is a recently identified mental health construct.
Currently, no widely accepted diagnostic criteria for SCT exist, and it is not recognized in
the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental
Disorders (5th ed.; DSM-5). There is debate in the psychological community as to
whether SCT is better conceptualized as an atypical presentation of attentiondeficit/hyperactivity disorder (ADHD) or a unique symptom cluster comprised of ADHD
and additional psychological and neurocognitive symptoms. When controlling for ADHD
symptomatology, SCT has been found to be associated with internalizing symptoms, such
as anxiety and depression, as well as impaired cognitive functioning, such as deficits in
executive function and slow processing speed. The current study examined groups of
adults diagnosed with varying levels of ADHD and SCT symptomatology to determine
whether they differed in their internalizing symptoms and cognitive functioning.
Analyses indicated subjects with clinical levels of both ADHD and SCT had higher
scores on measures of internalizing symptoms and executive dysfunction than those with
ADHD and subclinical symptoms of SCT or those with ADHD only. Regression analyses
identified symptoms of depression and executive dysfunction that significantly predicted
subjects SCT symptoms. It is hoped the current study will inform the assessment and
treatment of adults with ADHD, SCT, and internalizing symptoms.
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Chapter 1: Introduction
Statement of the Problem
The American Psychiatric Association’s (2013) Diagnostic and Statistical
Manual of Mental Disorders (5th ed.; DSM-5) defines attention-deficit/hyperactivity
disorder (ADHD) as a neurodevelopmental disorder that results in difficulty sustaining
attention, hyperactivity, and/or impulsive behavior that interferes with social, academic,
or occupational functioning (American Psychiatric Association, 2013). Sluggish
cognitive tempo (SCT) is a conceptualized as constellation of psychological symptoms
characterized by feelings of apathy and lethargy, difficulty concentrating, daydreaming,
and slowed cognition that negatively impacts mental health functioning (Becker &
Barkley, 2018). Initially hypothesized as a potential subset of ADHD symptomatology,
recent research has concluded that SCT is distinct from ADHD, and other mental health
disorders (Barkley, 2012, 2014; Becker, Marshall, & McBurnett, 2014). Although SCT is
recognized, by some, as a separate disorder from ADHD, approximately half of all adults
with clinically elevated symptoms of SCT have a co-occurring ADHD diagnosis
(Barkley, 2012).
A literature review of PsychINFO, Google Scholar, and Ebscohost revealed a
number of studies exploring how children and adults with ADHD and SCT differ in the
types of difficulties they experience. The most relevant are cited below. Studies of these
differences in children and adults found unique associations of SCT with internalizing
symptoms, lower academic performance, lower annual income, impaired organization
and problem solving skills, increased stress, and poorer quality of life, even when
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controlling for the influence of more widely-accepted ADHD symptoms (Becker et al.,
2018; Becker, Marshall, & McBurnett, 2014; Barkley, 2012; Combs et al., 2014, 2015).
Although SCT and ADHD are theorized to be distinct from one another, their
close relationship, along with SCT’s status as a newly identified and less well-defined
mental health construct makes SCT difficult to examine. At this point, it is unclear
whether SCT is a transdiagnostic factor present in many psychopathologies or is better
conceptualized as a distinct mental health issue or diagnosis (Lunsford-Avery & Mitchell,
2018). Few studies have examined both ADHD and SCT’s close relationship with
internalizing symptoms and various types of comorbid dysfunction or impairment
associated with these disorders in adult populations (Becker & Barkley, 2018).
Purpose of the Study
ADHD and SCT are two related but distinct psychological syndromes that are
both associated with impairment in social-emotional, academic, vocational, and executive
functioning (Becker & Barkley, 2018). SCT is still a relatively new psychological
construct that is poorly understood, due to the both complexity of the phenomenon and
limited research. At this point, it there is debate about whether SCT should be
conceptualized as a transdiagnostic factor present in many psychopathologies or as a
distinct mental health issue, which is more or less related to ADHD (Lunsford-Avery &
Mitchell, 2018). A small but growing number of studies have examined both ADHD and
SCT’s close relationship with internalizing symptoms and differences in the types of
comorbid impairment associated with these disorders in adult populations (Becker &
Barkley, 2018). This study examined how comorbid issues present in adults with varying
levels of SCT and ADHD. Specifically, this study sought to learn what, if any,
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differences exist between these groups in their internalizing symptoms and cognitive
functioning.
SCT and ADHD are distinct mental health constructs, with evidence for
comorbidity. By examining the differences in internalizing symptoms and cognitive
functioning in adults with varying levels of ADHD and SCT, it is hoped that this study
will better inform assessment and treatment planning for these often complex and
challenging cases. Gaining knowledge of these differences may improve clinicians’
capacity to differentiate between SCT and ADHD during their diagnostic process as well
as offer potential targets for treatment the clinician and client may not have initially
considered.
Consequently, this study compared subjects who meet criteria for adult ADHD
and SCT (ADHD + SCT), with subjects who meet criteria for ADHD with subclinical
levels of SCT (ADHD + subclinical SCT), subjects who only meet criteria for ADHD
(ADHD only), and subjects who only meet criteria for SCT (SCT only). These diagnostic
groups were compared on measures of internalizing symptoms and cognitive functioning.
In this way, the four groups could be compared to determine if there were significantly
different levels of internalizing symptoms and cognitive functioning. Furthermore, this
study analyzed subjects’ data to identify which variables are the best predictors of SCT
symptomatology.
Hypotheses
Hypothesis 1. There would be a significant difference between subjects
diagnosed with ADHD + SCT, ADHD + subclinical SCT, ADHD only, and SCT only,
with those diagnosed with ADHD + SCT having higher levels of internalizing symptoms
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than the other groups. For hypothesis 1 and hypothesis 2, ADHD was operationally
defined as meeting DSM-5 criteria for ADHD-In, ADHD-H/I, or ADHD-C as determined
by clinician ratings from the Structured Clinical Interview for DSM-5 Disorders (SCID5). SCT was operationally defined as a score of 93rd percentile or higher for the subjects’
reference age group on the BAARS-IV SCT subscale (the threshold for clinically
significant levels of SCT outlined in the BAARS-IV manual). Subjects whose SCT
scores are in the Borderline range as outlined in the BAARS-IV manual (85th to 92nd
percentile) do not meet criteria for SCT while still having notable levels SCT
symptomatology. Their borderline impaired scores do not allow SCT to be easily
classified as present or absent. This presentation of SCT is referred to as “subclinical
SCT” for comprehension’s sake. Subjects were considered to not meet criteria for SCT if
their scores on the BAARS-IV SCT subscale were at the 84th Percentile or lower
(reflecting nonsignificant or marginal levels of SCT as outlined in the BAARS-IV
manual). Internalizing symptoms were operationally defined as scores on the BDI-II,
Penn State Worry Questionnaire (PSWQ), the affect subscale of the Brown Attention
Deficit Disorder Scale-Adult Version (BADDS), and Neuroticism scale of the NEO-PI-R.
Hypothesis 2. There would be a significant difference between subjects
diagnosed with ADHD + SCT, ADHD + subclinical SCT, ADHD only, and SCT only,
with those diagnosed with ADHD + SCT exhibiting significantly more impaired
cognitive functioning than all other groups. Cognitive functioning was operationally
defined as subjects’ performance on the Coding task and Digit Span task of the WAISIV, and total executive functioning summary score of the BDEFS.
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Hypothesis 3. Anxiety and deficits in executive functioning will predict the level
of SCT after accounting for ADHD symptomatology. SCT was operationally defined as
subjects’ percentile rank on the BAARS-IV SCT subscale (with 93rd percentile and above
representing clinically significant levels of SCT). Anxiety was operationally defined as
subjects’ scores on the PSWQ. Executive functioning was operationalized as subjects’
total executive functioning summary score of the BDEFS. ADHD symptomatology was
operationally defined as subjects’ scores on the DSM-IV Inattentive symptoms and DSMIV Hyperactive/Impulsive symptoms scales of the CAARS.
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Chapter 2: Review of the Literature
Attention-Deficit/Hyperactivity Disorder in Adults
ADHD is typically thought of as a disorder of childhood, but the identification of
a 4.4% prevalence of the disorder in adults has been gaining increasing attention among
clinicians and researchers in recent years (Kessler et al., 2006). The DSM-5 uses two
symptom dimensions, inattention and hyperactivity/impulsivity, to identify three
recognized subtypes of ADHD: predominantly inattentive type (ADHD-In),
predominantly hyperactive-impulsive type (ADHD-H/I), and the combined type (ADHDC) (American Psychiatric Association, 2013). The combined subtype is the most common
in adults, with approximately 62% of adults exhibiting ADHD-C, 31% exhibiting
ADHD-In, and 7% exhibiting ADHD-H/I. The prevalence of ADHD-C and ADHD-In in
adults indicates that upwards of 90% of those with adult ADHD exhibit clinically
significant levels of inattentive symptoms (Wilens et al., 2009). These rates indicate that
the majority of adults diagnosed with ADHD experience symptoms from the inattentive
domain of ADHD. Several symptoms of ADHD in adults are nonspecific and can stem
from other forms of neurological impairment or difficulties caused by another mental
health issue.
ADHD is highly comorbid with many other mental health disorders, including
anxiety disorders, mood disorders, substance use disorders, and intermittent explosive
disorder (Kessler, et al., 2006). Individuals with adult ADHD have a higher lifetime
comorbidity rate of internalizing disorders and externalizing disorders compared to the
general population. These include internalizing disorders such as depressive disorders,
anxiety disorders, and cluster C personality disorders; as well as externalizing disorders
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such as Cluster B personality disorders, conduct disorder, and oppositional defiant
disorder (Jacob et al., 2014). High levels of effortful control and low stress levels are
protective factors against internalizing disorders (Gulley et al., 2017).
Models of Attention and Executive Functioning.
Deficits in attention and self-control (a lack of inhibition) are central to ADHD
symptomatology. Many models of attention and self-control attribute the symptoms of
ADHD and SCT to a deficiency or failure of neuropsychological processes. This failure
has a downstream effect on the capacity to self-regulate behavior.
An earlier model of ADHD, the self-regulation model, posited by Russell Barkley
(1997) conceptualizes ADHD as the expression of severely impaired inhibition. In his
model Barkley defines inhibition as “performance on cognitive and behavioral tasks that
require withholding of responding, delayed responding, cessation of ongoing responses,
and resisting distraction or disruption by competing events” (Barkley, 1997, p. 68). When
the cognitive processes that control inhibition are impaired or dysregulated, cognition
becomes overburdened by an unfiltered stream of stimuli and individuals are less capable
of self-regulating responses to said stimuli. Deficits in inhibition lead to thoughts and
behaviors being influenced more by immediate rewards than by long-term goals or
executive functioning (Barkley, 1997). The degree to which one is capable of resisting
stimuli irrelevant to their current goal is defined as persistence. The weaker or more
dysfunctional the executive functions that control inhibition, the less persistent one is in
tasks, resulting in the hyperactive/impulsive and inattentive behavior characteristics of
ADHD (Barkley, 1997; Ducey, 2016).
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Barkley’s more recent self-regulation model belongs to the executive function
theory of ADHD. Broadly speaking, executive functioning is a set of top-down mental
abilities that requires the collaboration of different cognitive and neuropsychological
processes. These processes work together to help an individual monitor and regulate
one’s own behavior over time towards the achievement of a goal or to solve a novel
problem. When a person’s mental abilities are insufficient to adequately monitor and
regulate one’s own behavior and as a result, the individual is having difficulty attaining a
goal or solving a novel problem, they are said to be experiencing executive dysfunction.
Multiple researchers have proposed that deficits in a specific executive function or broad
deficits in executive functioning are the source of the inattentive, hyperactive, and
impulsive symptoms of ADHD (Willcutt et al., 2005). Research consistently finds
significant relationships and moderate effect sizes in executive functioning deficits and
ADHD symptomatology. The most consistent executive functioning deficits related to
ADHD are in inhibition, vigilance/sustained attention, working memory, and planning
(Willcutt et al., 2005).
Another model of attention difficulties in a variety of disorders is Posner’s model
of attention. Posner’s model posits that separate neurocognitive systems are in charge of
alerting responses to the appearance of new stimuli; orienting to said stimuli; and
executive control of thoughts, actions, and emotions in response to these stimuli (Becker
& Willcutt, 2018). Some have theorized that deficiencies in the orienting system may be
the cause of SCT symptomatology whereas ADHD symptoms represent deficiencies in
all three systems (Barkley, 2016; Becker & Willcutt, 2018).
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Sluggish Cognitive Tempo
Validating SCT.
In the 1980s, the delineation between the two symptom dimensions of ADHD
(then known as Attention Deficit Disorder; APA, 1987) was codified into the third
edition of the Diagnostic and Statistical Manual of Mental Disorders. This change was
made to account for children who presented with inattentive but not hyperactive
symptoms of ADHD. Following the release of the DSM-III, researchers set out to
examine the differences between these two symptom domains.
The first of several factor analytic studies examining the symptoms and related
behaviors of children with ADHD examined the factors that emerged from behavior
rating scales of children with ADHD (Neeper & Lahey, 1986). They found that a threefactor model provided the best fit for ADHD. In addition to the expected inattentive and
hyperactive factors, a “slow tempo” factor emerged. Across multiple studies of ADHD
symptoms and related behaviors in children, these three factors: hyperactivity–
impulsivity, inattention–disorganization, and “slow tempo” have emerged (Bauermeister
et al., 2012; Becker, Marshall, & McBurnett, 2014). As research progressed, researchers
grouped the constellation of symptoms and behaviors related to the slow tempo factor
under the label sluggish cognitive tempo (SCT).
The SCT factor consisted of items that captured behaviors described as sluggish,
apathetic, lethargic, drowsy, and being “in a world of his or her own.” Another factor
analytic study found 13 features that showed good factor loadings with SCT. This
included sluggishness, being tired or lethargic, slow thinking/processing, loses train of
thoughts easily, sleepy or drowsy, spacey, daydreaming, being “in a fog,” being
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underactive or slow moving, getting lost in thought, staring blankly into space, easily
confused, and being apathetic or unmotivated. Further studies showed that SCT
symptoms were uniquely elevated in children with ADHD-In compared to ADHD-H/I.
(Becker, Marshall, & McBurnett, 2014). Studies of children from general population and
clinical samples identified the presence of SCT in children without clinical levels of
ADHD symptomatology and found SCT symptoms to be associated with inattentive
symptoms (Garner et al., 2010; Wåhlstedt & Bohlin, 2010).
In 1987, changes in the revised edition of the DSM-III eliminated the new
practice of diagnosing ADHD subtypes (APA, 1987). This had the inadvertent effect of
exiling SCT from entering the official nosology used to diagnose ADHD (Becker,
Marshall, & McBurnett, 2014). In spite of increased research interest in this third
dimension of ADHD and evidence that SCT represented a distinct and important domain
of attentional problems in those with ADHD, SCT remains unincorporated into the
official nosology of ADHD to this day (Becker, Marshall, & McBurnett, 2014). The
current conceptualization of SCT describes it as a set of symptoms characterized by
feelings of apathy and lethargy, difficulty concentrating, and slow cognitive processing
speed, with strong relationships to established ADHD symptom dimensions (Becker &
Barkley, 2018).
As clinical and research interest in adult ADHD grew, interest in whether SCT
presented in adults followed close behind. Several comprehensive studies were conducted
by Dr. Russell Barkley as part of the development of the fourth edition of the Barkley
Adult ADHD Ratings Scale (BAARS-IV). The BAARS-IV is a self- and other-report
instrument designed to measure the inattentive, hyperactive, and impulsive symptoms of
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ADHD in adults ages 18-89. For the fourth edition, -nine items used in prior studies of
SCT in children were added to the BAARS-IV measure. These SCT items and other
items on the BAARS-IV used to assess for ADHD symptomatology in adults were
administered to a normative sample of the general population consisting of 1,249 adults
in the United States. Barkley proposed that an individual must score higher than the 93rd
percentile of the adults in the sample within the same age bracket on the SCT subscale of
the BAARS-IV before they are considered to have clinically significant levels of SCT
(Barkley, 2011a). The SCT subscale measures chronic daydreaming, hypoactivity, mental
“fogginess,” and difficulty sustaining concentration and alertness during boring tasks.
Later studies by Barkley used the same normative sample of the general
population in the Unites States to conduct multiple factor analyses examining differences
between adults whose SCT scores were in the 95th percentile or higher of the normative
sample with those whose ADHD scores were in the 95th percentile or higher. This
research confirmed that the chronic daydreaming, hypoactivity, mental fogginess, and
tendency to become bored easily, characteristic of SCT, aligns with a different factor than
the hyperactive-impulsive and inattentive dimensions of ADHD (Barkley, 2011a).
Barkley determined that, of the participants who met the criteria for clinical levels
of SCT, 54% also met the criteria for a diagnosis of ADHD. Similarly, 46% of those
diagnosed with ADHD also met criteria for clinical levels of SCT. This overlap between
the two disorders is attributed to participants with SCT and/or ADHD both sharing high
levels of inattentive symptoms (Barkley, 2012). SCT symptoms shared as much as 50%
of their variance with inattentive symptoms but less than 25% of the variance with
hyperactive/impulsive symptoms. Furthermore, SCT scores were associated with
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impairment in social, academic, and emotional functioning, even after controlling for
comorbid ADHD symptomatology (Becker & Barkley, 2018). Based on these findings,
Barkley concluded elevated SCT symptoms likely reflect a separate disorder from ADHD
that is comorbid in approximately half of adults with ADHD (Barkley, 2012).
Another study set out to examine the reliability and validity of SCT measures in
an applied clinical setting. Lunsford-Avery et al. (2018) examined client data from a
medical center’s outpatient specialty clinic for ADHD. This data was collected as part of
the initial psychological evaluations of new clients presenting for services at the program.
They found the SCT subscale on the BAARS-IV to be reliable and valid for use in this
outpatient clinical setting.
Exploratory factor analysis also found the SCT items of the BAARS-IV clustered
into three factors: sleepy/sluggish, low initiation/persistence, and slow/daydreamy. The
low initiation/persistence and slow/daydreamy factors were significantly correlated with
both inattentive and hyperactive/impulsive symptoms of ADHD. The sleepy/sluggish
factor was positively associated with inattention but not hyperactivity/impulsivity
(Lunsford-Avery et al., 2018).
Empirical studies with large samples of adults and children in a variety of settings
have demonstrated that SCT is a distinct psychological construct, which is comorbid in
approximately half of adults with ADHD, particularly so in inattentive presentations
(Barkley, 2011a, 2012; Becker et al., 2016; Garner et al., 2010; Wåhlstedt & Bohlin,
2010). The development and application of measures for SCT have made it possible to
measure SCT in research participants, clinical samples, and the general population
(Barkley, 2011a, 2012; Lunsford-Avery et al., 2018). Researchers are able to examine the
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subtle differences in how SCT and ADHD relate to each other, in addition to other mental
health disorders.
Depletion Models and SCT.
The resource model of control posits that the ability to -control one’s behavior
including thoughts, emotions, and actions relies on limited resources that are depleted as
an individual exercises self-control. This model defines self-control as a “resource” of
ability or that allows an individual to attain personal goals by choosing larger but delayed
long-term rewards over smaller but immediate sources of gratification. As this resource is
depleted, it becomes more and more difficult for the individual to monitor and selfcontrol their behavior, resulting in a state referred to as “ego-depletion” (Baumeister,
2002). Whereas the original theory posited that blood glucose might be the resource
depleted by this process, later research demonstrated this was not the case (Gailliot et al.,
2007; Inzlicht & Schmeichel, 2012).
Inzlicht and Schmeichel proposed a revised version of the resource model. Their
process model of depletion argues that exerting self-control influences motivation and
attention, which increases the likelihood of a failure in self-control. As mental effort is
exerted to maintain self-control, motivation begins to shift away from the goal or reason
for expending effort to maintain self-control (e.g., motivated to maintain a diet) and
towards a more immediate source of gratification (e.g., motivated to eat ice cream). This
shift in motivation is coupled with a shift in attention. As one exerts effort to maintain
self-control, attention shifts away from stimuli or information that they need to continue
to exert self-control (e.g. focusing on how eating ice cream conflicts with a dieting goal)
and towards potentially rewarding stimuli (e.g. focusing on how delicious ice cream
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looks). Inzlicht and Schmeichel proposed ways to counteract the ego-depletion effect,
such as presenting cues to help refocus attention on reasons for self-control and providing
rewards or incentives for sustaining self-control, which would increase motivation
A study examining the ego-depletion paradigm in adults with ADHD compared
participants with a history of ADHD and a control group without ADHD on their
performance on a handgrip stamina task and computerized gambling task following a
continuous performance task. Continuous performance tasks require prolonged, sustained
attention and are notoriously frustrating and boring. They are thought to be a good way to
induce ego depletion and measure sustained attention in a laboratory setting. The
handgrip stamina task and computerized gambling task were used to operationalize selfcontrol for this study (Lubusko, 2005).
The continuous performance task was administered to both groups to cause egodepletion. Participants’ performance on the gambling task and handgrip task were then
measured and compared. Results indicated no differences between the participants with
ADHD and without ADHD on their performance on the gambling task and handgrip task
following the continuous performance task. This indicates that there was no observed
difference between the participants with ADHD and without ADHD in the degree of egodepletion they experienced (Lubusko, 2005).
Although these findings do not support the idea of more severe ego-depletion in
adults with ADHD, it is important to consider alternative models of resource depletion
and limitations to the design of the study. This study was conducted before Inzlicht and
Schmeichel published their model. Considering these findings in the light of the process
model of depletion, the participants were first given a task that potentially depleted their
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attention and motivation, then showed no between groups differences on measures of
impulsivity, persistence, and decision making. The continuous performance task may
have decreased participants’ attention and motivation, but changes in attention and
motivation were not measured in this study. The gambling task was originally designed to
measure decision-making and impulsivity and the handgrip task was designed to measure
persistence and physical stamina (Lubusko, 2005). Retrospective consideration of these
findings indicates that the researchers may have erroneously used measures of
impulsivity and physical exertion to examine the depletion of self-control.
Individuals with ADHD struggle to regulate attention, sustain motivation, exhibit
self-control, and activate other executive functions (American Psychiatric Association,
2013; Barkley, 2011b; Willcutt et al., 2005). If attention and motivation play a key role in
sustaining self-control as posited by the process model of depletion, then those with
ADHD would have a particularly difficult time exhibiting self-control due to their
impaired attention and motivation processes, not just because of depletion of a general
self-control resource.
A study comparing children with ADHD and typically developing children on a
continuous performance task found modest evidence for this model. A continuous
performance task was administered to all participants twice: once to cause ego-depletion,
induced by prolonged sustained attention to boring stimuli, and a second to measure
performance. Half of the children with ADHD and half of the typically developing
children were offered token reinforces for good performance on the continuous
performance task that could be exchanged for a small toy at the end of the experiment
(Dekkers et al., 2017).
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The children with ADHD exhibited significantly more omission errors and greater
reaction time variability, both of which are measures of basic attention and common in
ADHD (Dekkers et al., 2017), than the control group on the initial continuous
performance task. The ADHD and control groups did not differ significantly on measures
of inhibition or reaction time (measures of self-regulation) on the initial task. Children
with ADHD and typically developing children who were offered reinforcement for their
performance on the second administration of the task all showed less reaction time
variability and fewer omission errors than those who were not. Furthermore, participants
with ADHD who were offered reinforcement performed better than those with ADHD
who were not given reinforcement for their performance. Reinforcement effects did not
differ between children with ADHD and typically developing children. One potential
explanation for the lack of difference in reinforcement effects put forth by the authors is
the elevated reward threshold in children with ADHD. The inexpensive toy might have
been an insufficient reward to instill high levels of motivation in children with ADHD,
but was a sufficient reward to produce moderate levels of motivation found in typically
developing children (Dekkers et al., 2017).
The results of this study suggest ego-depletion had an impact on measures of
basic attention but not self-regulation. This decrease in attention was more prevalent in
children with ADHD, possibly due to their already impaired capacity to sustain attention.
The ego-depletion effect on attention was mitigated by increasing motivation through an
external reward, and this mitigating effect brought the performance of children with
ADHD to the same level as typically developing children (Dekkers et al., 2017). The
original resource model of control and the notion of ego-depletion have come under
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scrutiny due to several conflicting meta-analyses and replication studies (Hagger et al.,
2016; Pollert, 2015). However, these findings suggest that the process model of depletion
may accurately describe the relationship between sustained effort, motivation, and
attention in those with impaired executive functioning, including those with ADHD and
potentially SCT. To date, a literature review reveals no studies specifically examining
SCT in relation to the resource model of control or process model of depletion.
Nosology and Transdiagnostic Factors
The DSM-5 conceptualizes mental health disorders in categorical terms, requiring
a diagnostic threshold of symptoms and other criteria before diagnostic criteria are met
for various disorders. The DSM-5 classifies disorders with similar features, etiology, and
diagnostic criteria into categories of related disorders; for instance, neurodevelopmental
disorders or psychotic disorders. In the past, disorders in different categories were
presumed to have independent etiologies and share few features in common (American
Psychiatric Association, 2013). Whereas this framework makes psychopathology easier
to diagnose and classify, it is recognized that “the boundaries between many disorder
‘categories’ are more fluid over the life course . . . and many symptoms assigned to a
single disorder may occur, at varying levels of severity, in many other disorders,”
(American Psychiatric Association, 2013, p. 5). Furthermore, individuals with a mental
health disorder are more likely to present with multiple diagnoses than with a single
disorder (Kessler et al., 2005). Additionally, those who present with symptoms that are
subthreshold to the diagnostic criteria of a disorder can still experience clinically
significant distress and impairment in their lives (Krueger & Eaton, 2015). The high
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prevalence of comorbidity and overlap of symptomatology in various mental health
diagnoses indicated that there might be common factors shared between many disorders.
Internalizing and Externalizing Factors
According to the theory of transdiagnostic factors (TDFs), many psychological
disorders with similar features (such as disorders of anxiety and mood) are hypothesized
to stem from one or two underlying core problems, in this case, internalization and
externalization of negative affect. When individuals experiences distress or is attempting
to cope with negative emotion, they can choose to internalize these problems by keeping
these feelings inside or, otherwise, not acknowledging how they feel. They could also
externalize their problems and direct these negative feelings away from themselves by
acting out towards people or objects in their environment. According to this theory, these
underlying factors express themselves as different disorders depending on each
individual’s unique characteristics and experiences (Krueger & Eaton, 2015).
One of the first and most prominent theories of TDFs posited the distinction
between internalizing and externalizing factors in mental health disorders (Achenbach,
1966). A factor analytic study of psychopathology in children with a variety of mental
health disorders identified that their symptoms broadly loaded onto these two factors:
internalizing and externalizing (Achenbach, 1966). The internalizing factor consisted of
symptoms and behaviors directed inwards and influence the individual’s internal
psychological experience, such as anxiety, depressive symptoms, social withdrawal and
isolation, somatic complaints, and traumatic stress. The externalizing factor consisted of
symptoms and behaviors directed outwards on the individual’s environment, such as
disruptive, hyperactive, and aggressive behaviors. (Jacob et al., 2014). Later research has
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validated the existence of these externalizing and internalizing factors in a variety of
populations (Krueger & Eaton, 2015).
Additional TDFs have been proposed representing common factors to a large
number of psychopathologies, which do not load onto the externalizing or internalizing
factors. These include, but are not limited to, a thought disorder factor, which is common
to schizophrenia and other psychotic disorders, and an autism factor, which is unique to
individuals across the autism spectrum (Krueger & Eaton, 2015). Others contend that
even these factors could be attributed to internalizing or externalizing factors. Following
the identification of SCT in the mid-1980s, subsequent research has investigated whether
SCT is another subtype of ADHD, a distinct mental health disorder, or a TDF that
contributes to multiple mental health disorders.
There is currently no consensus regarding the core constructs or nosology used as
a comprehensive definition of SCT (Becker et al., 2016). A meta-analysis evaluating the
validity of SCT as a diagnostic construct identified 18 potential core features of SCT
across multiple disparate measures used by researchers to measure SCT. Of these 18 core
features, only 13 showed good factor loadings onto the SCT factor in this meta-analysis,
and encompassed the cognitive and behavioral features of SCT (Becker et al., 2016). The
other five domains had insufficient factor loadings or loaded stronger onto other factors
such as ADHD-In symptoms or depression. The SCT construct demonstrated good
internal validity and moderate external validity across the studies examined. Moderate
and significant correlations were found between SCT ratings and nearly all of the other
psychopathologies examined in this study. However, none of these associations were
high enough that SCT could be considered a redundant conceptualization of a preexisting

ADULTS WITH ADHD AND SLUGGISH COGNITIVE TEMPO

21

psychiatric disorder, supporting the notion that SCT is a separate construct from other
better established and defined established psychopathologies. However, to date, there is
still insufficient research on SCT to determine if it is best conceptualized as an
independent psychiatric disorder or better understood as a syndrome or TDF that is
present across many pathologies (Becker et al., 2016).
Internalizing Disorders in Those With SCT and ADHD
A handful of studies have investigated the relationships between SCT; the
inattentive, hyperactive, and impulsive presentations of ADHD; and internalizing
disorders. Symptoms of internalizing disorders include anxiety, depression, social
withdrawal, isolation, somatic complaints, and traumatic stress. Anxious and depressive
disorders are two of the most common mental health issues in the population. A national
survey by the American Medical Association examined the prevalence of mental health
diagnoses from the DSM-IV in the United States. They found anxiety disorders to be the
most prevalent class of disorders, with 28.8% of the population sample meeting criteria
for an anxiety disorder at some point in their life. More specifically, the survey also
found that the four most prevalent mental health disorders were major depressive disorder
(16.6% prevalence), alcohol abuse (13.2%), specific phobia (12.5%), and social
phobia/social anxiety disorder (12.1%) (Kessler, Berglund, Demler, Jin, Merikangas, &
Walters, 2005).
Anxiety disorders are characterized by excessive fear and anxiety, leading to
behavioral disturbances. Fear is the negative emotional response to a real, imminent
threat to one’s well-being, whereas anxiety is the anticipation of future threat (American
Psychiatric Association, 2013). Anxious symptoms can occur in response to real threats
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to an individual, and typically dissipates after the threat is gone. Anxiety is considered
pathological when it regularly occurs in response to perceived, rather than actual threats
or is disproportionate to the actual threat posed to the individual. Depressive disorders are
characterized by sadness, irritability, and feelings of emptiness, that are accompanied by
somatic and cognitive changes. These depressive symptoms significantly impair
functioning (American Psychiatric Association, 2013).
Studies of SCT in adults and children have found it to be significantly associated
with internalizing symptoms including social withdrawal, somatic complaints, anxious
symptoms, and depressive symptoms (Bauermeister et al., 2012; Becker, Langberg, et al.,
2014). Studies examining externalizing symptoms have found them to be unassociated or
negatively associated with SCT when controlling for the influence of ADHD symptoms
(Becker, Marshall, & McBurnett, 2014; Becker, & Langberg, 2013). These findings
illustrate that SCT and ADHD each have a unique relationship with internalizing
symptoms, whereas externalizing symptoms are related to ADHD but not SCT.
This research has established that both ADHD and SCT are related to anxiety and
depression. However, the close relationship between ADHD and SCT warranted
examination as to whether the relationship between anxious and depressive symptoms
and ADHD could be attributable to SCT or vice versa. An additional layer of difficulty
comes from the challenge of measuring symptoms of anxiety in those with the
hyperactive symptoms of ADHD, whose chronic restlessness and higher levels of
physiological arousal can be mistaken for anxiety (Meyer, Miller, Metzger & Borkovec,
1990; Ramsay, 2015). Furthermore, individuals with ADHD may underreport their level
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of impairment on self-report measures due to a lack of self-awareness on their behavior
(Manor et al., 2012).
One study examining ADHD, SCT, and internalizing symptoms examined the
symptom profiles of 2,744 children diagnosed with the Inattentive or Combined subtype
of ADHD. Their information was collected as part of a larger study examining the
effectiveness of mental health service delivery across nine predominantly low-income
school districts in Texas. Children with ADHD-In were sorted into a high SCT or low
SCT group based on whether they had elevated scores on two items from a teacher rating
scale examining the SCT symptoms of “daydreams or gets lost in his/her thoughts” and
“underactive, slow moving, or lacks energy” (Carlson, & Mann, 2002).
These students were also administered the teacher rating form of the Adjustment
and Behavior Problems Scales (TRF-ABPS), a standardized measure of various
childhood behavior problems and functioning rooted in Achenbach’s theory of
internalizing and externalizing disorders. The TRF-ABPS includes an overall
internalizing behavior composite score calculated from subscales examining symptoms
such as acting withdrawn, somatic complaints, anxious/depressed symptoms, and social
problems. The TRF-ABPS also includes an overall externalizing symptoms composite
score consisting of subscales examining delinquency and aggressive behavior
(Achenbach, 1991).
Pairwise analyses of variance revealed teachers rated children in the high SCT/In
group significantly higher on the internalizing subscales of overall internalizing behavior,
acting withdrawn, and somatic complaints on the TRF than those in the low SCT/In
group and those in the ADHD-C group. Children in the high SCT/In group were rated
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significantly lower on the externalizing subscale of aggressive behaviors than those in the
low SCT/In group and those in the ADHD-C group. Although this study was severely
limited by failure to control for SCT levels in the ADHD-C group and the use of only two
items from a teacher rating scale to measure SCT, it is one of the first to demonstrate that
children with ADHD and SCT can be distinguished from those with only ADHD based
on co-occurring mental health symptoms (Carlson & Mann, 2002).
A series of additional studies examining the relationship between SCT, ADHD,
anxiety, and depression in adults utilized a nonclinical sample of undergraduate students,
ranging in age from 17 to 34. Hierarchical linear regression examined SCT’s relationship
with anxiety and depression and academic adjustment while controlling for demographic
variables and the inattentive, hyperactive, and impulsive symptoms of ADHD (Becker,
Langberg, et al., 2014). The Depression Anxiety Stress Scales (DASS-21) were used to
assess the degree of depression and anxiety participants had experienced in the past week.
Previous studies of the DASS-21 have demonstrated its internal consistency and
concurrent validity with other measures of depression and anxiety (Antony, Bieling, Cox,
Enns, & Swinson, 1998).
Preliminary correlations were used to identify which demographic variables and
ADHD symptoms would be appropriate to use as predictors in the analyses. Comparisons
were made between two regression models. The first model used the age, sex, and the
inattentive, impulsive, and hyperactive subscales from the BAARS-IV as predictors, and
a second model that added in the SCT subscale of the BAARS-IV as an additional
predictor. These models were used to predict scores on measures of anxiety, depression,
and other measures of academic success (Becker, Langberg, et al., 2014).
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Comparisons between the two models’ ability to predict anxiety scores on the
DASS-21 found that the model which included SCT as a predictor explained 6% more of
the variance than the model which excluded SCT. Furthermore, adding SCT scores as a
predictor in step two reduced inattentive symptoms and impulsive symptoms ability to
predict anxiety to nonsignificance. Comparisons between the two models’ ability to
predict depression scores on the DASS-21 found the second model including SCT
explained an additional 8% of the variance compared to the first model. In the first
model, inattentive and hyperactive symptoms were found to be significant predictors of
depression. In the second model, only SCT emerged as a significant predictor of
depressive symptoms. (Becker, Langberg, et al., 2014).
Another study in this series tested to see if SCT symptoms would continue to be
the only significant predictor of depression in a sample of college students, in the same
age range, who met the criteria for ADHD-In or ADHD-C. The model in step one utilized
ADHD subtype as a categorical variable, age, and a continuous measure of current
mental health service use. The second added the SCT subscale of the BAARS-IV.
Consistent with the first study, the model including SCT explained an additional 8% of
the variance explained compared to the first model (ΔR2 = .08, ΔF(1, 67) = 7.67, p < .01).
Age remained a good predictor of depression in both models, but neither ADHD subtype
nor current mental health treatment usage were significant predictors of depression as
measured by the DASS-21 in either model (Becker, Langberg, et al., 2014).
Another study examined whether there were differences between adults diagnosed
with ADHD who were taking stimulants to treat their symptoms compared to those with
adult ADHD who were unmedicated. Separate regressions were run for each group using
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scores on measures of anxiety and depression, and SCT. Participants’ SCT levels, as
measured by the BAARS-IV, were correlated with ADHD symptomatology in both
groups. (Leikauf & Solanto, 2017). The State-Trait Anxiety Inventory (STAI) measured
participants’ anxiety and the Beck Depression inventory (BDI-II) measured their
depression. The STAI is a clinical measure examining the extent a participant is
experiencing anxiety in the moment (state anxiety) and their general tendency to respond
to stressful situations and events with anxiety (trait anxiety; Spielberger, 1989). The BDIII is a widely used self-report measure designed to examine the severity of depression
within the past two weeks (Beck et al., 1996). A multitude of studies have confirmed the
reliability and validity of the BDI-II in measuring the severity of depressive
symptomatology across different cultural groups and clinical populations (APA, 2019).
The reliability and validity of the STAI as a measure of both state and trait anxiety has
been verified by its creators (Spielberger et al., 1983; Spielberger, 1989).
Participants’ scores on trait anxiety and state anxiety on the STAI and their scores
on the BDI-II were significantly positively correlated with SCT in the unmedicated
group, but were not significant in the group taking stimulants (Leikauf & Solanto, 2017).
The executive functioning results of this study are discussed below. Because there were
no premedication measurements of the participants, anxiety and depression levels, it is
uncertain whether these findings were due solely to the effect of stimulant use or to
another difference between the unmedicated group and group using stimulants (Leikauf
& Solanto, 2017).
A recent study of SCT in adults with current ADHD symptomatology sorted
participants into three groups, based on whether they exhibited minimal, moderate, or
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severe levels of SCT as measured by the BAARS-IV. Researchers used MANOVAs to
compare the three groups across their presenting levels of internalizing symptoms,
anxiety, depression, externalizing symptoms, neurocognitive measures, and ADHD
related impairment while controlling for the influence of inattentive symptoms and
biological sex. Internalizing, anxiety, and externalizing symptoms were measured by the
Achenbach System of Empirically Based Assessments, Adult Self-Report (ASEBA). The
ASEBA measure is similar to the TRF-ABPS in its use of self-report scales to examine
symptoms indicative of internalizing, externalizing, or anxious symptomatology rooted in
Achenbach’s theory of TDFs. Reliability and validity of this measure has been
established by its authors (Achenbach & Rescorla, 2003). Depressive symptoms were
measured by the Center for Epidemiological Studies Depression Scale, a self-report
measure examining symptoms associated with depression experienced within the past
week (CES-D; Radloff, 1977). Participants in the moderate and severe SCT groups
exhibited significantly higher scores on the ASEBA scale measuring anxiety and the
CES-D measuring depression than those in the minimal SCT group (Kamradt et al.,
2018). The neurocognitive findings in this study are detailed below.
In summary, the aforementioned studies have demonstrated that levels of SCT are
positively related to internalizing symptoms such as anxiety and depression. Multiple
studies have confirmed this relationship in children, older adolescents, and adults when
controlling for symptoms of ADHD and demographic variables. The SCT subscale of the
BAARS-IV demonstrated consistent and strong associations across studies with a variety
of measures used to operationalize anxiety and depression. This pattern of similar
findings across studies using a variety of measures is evidence of a consistent association
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between SCT and symptoms of both anxiety and depressive symptoms. Furthermore, the
results of these studies suggest that the relationship between ADHD and anxiety and
depression may be partially explained by SCT (Becker, Langberg, et al., 2014). One
theory on the close relationship between these constructs posits that SCT, anxiety, and
depression may share several core features such as apathy, rumination/daydreaming,
inactivity, and decreased effort (Smith & Langberg, 2017).
Neurological Research on ADHD
ADHD is a neurodevelopmental disorder characterized by difficulty sustaining
attention, hyperactivity, and/or impulsive behavior. These symptoms are commonly
attributed to structural differences in the brain and dysfunction in the creation and
distribution of dopamine in the brain (Rubia et al., 2014; Wiers et al., 2018).
Brain Structure and Function in ADHD
The majority of brain imaging studies on ADHD has been conducted on children.
These studies have used magnetic resonance imaging (MRI) and diffusion tensor imaging
(DTI) to examine abnormalities in the brains of those with ADHD. Structural anomalies
in the frontal, parietal, striatal, and cerebellar regions of the brain, and the white matter
networks that connect them are closely associated with ADHD symptomatologyin
children (Rubia et al., 2014). The few published brain imaging studies of adults with
ADHD have found moderate structural abnormalities in these same brain regions (Rubia
et al., 2014). Meta-analyses of imaging studies have concluded that abnormalities in the
basal ganglia are the most consistently found structural abnormality in the brains of those
with ADHD (Rubia et al., 2014). The structures that make up the basal ganglia (including
the caudate nucleus, putamen, globus pallidus, and substantia nigra) contribute to
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processes such as voluntary motor movement and inhibitory control, the reward system
and motivation, and dopamine synthesis (Kolb & Whishaw, 2015; Rubia et al., 2014).
Additional structural abnormalities include reduced grey matter volume in the
prefrontal cortex of individuals with ADHD compared to typically developing individuals
of the same age (Rubia et al., 2014). Rather than reflecting a consistent structural
abnormality, longitudinal research has found that the difference is due to a delay in
cortical development (Kolb & Whishaw, 2015; Shaw et al., 2007; Rubia et al., 2014). The
human prefrontal cortex controls cognitive processes that allow the selection of behaviors
or actions to engage in based on internal, external, and context cues. The prefrontal
cortex also contributes to our knowledge of our autobiographical experiences and
personal goals, which is referred to as autonoetic awareness (Kolb & Whishaw, 2015).
Delayed development in the prefrontal cortex may contribute to the impaired selfregulation of behavior seen in ADHD due to impaired ability to attend to context cues
and long-term goals.
Few studies have attempted to differentiate between subtypes of ADHD or
between ADHD and SCT using brain-imaging techniques. One such study on ADHD
compared the performance of school age children with ADHD-In to those with ADHD-C
on a go/no-go task. Go/No-go tasks measure the ability to inhibit responding via button
press to a decoy stimulus, which looks similar to a target stimulus to which the
participant is supposed to respond to. During the go/no go task, functional and structural
MRIs were taken. Analysis of performance revealed no significant differences between
the ADHD-In and ADHD-C groups on performance of the go/no-go task itself. All
participants exhibited activation of the temporoparietal junction and right ventrolateral
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prefrontal cortex during successful inhibition on the go/no-go task. These areas have been
found to be involved with detecting external cues for behaviors and signaling for the
suppression of behavior, respectively (Solanto et al., 2009). Children with ADHD-In
demonstrated a greater magnitude of activation in temporoparietal junction, despite the
ADHD-In and ADHD-C groups having nonsignificant differences in performance. These
findings imply that the brains of those with ADHD-In require greater activation of the
temporoparietal junction to achieve the same level of performance as those with ADHDC (Solanto et al., 2009).
A similar study compared fMRI scans of typically developing adolescents and
adolescents with ADHD-In during a response inhibition task. The relationship between
SCT symptomatology and levels of brain activation in different regions was examined
using regression analysis. Activation in the superior parietal lobule during the inhibition
task was negatively correlated with parent ratings of SCT symptoms (Fassbender et al.,
2015). The superior parietal lobule receives sensory input from the eyes and hands, and
assists the rest of the parietal lobe in integrating sensory information. The authors posit
that the negative relationship between superior parietal lobule activation during the
response inhibition task and SCT symptoms may represent impairment in the ability to
reorient attention to a new stimulus (Fassbender et al., 2015). This theory is consistent
with Posner’s model of attention, which is discussed later.
The Dopaminergic System
Dopamine is an amine that functions as both a hormone and neurotransmitter in
the human body. Nuclei in the substantia nigra and ventral tegmentum synthesize
dopamine and distribute it via long axon pathways throughout the central nervous system.
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Dopaminergic pathways consist of the nigrostriatal pathway and mesolimbic pathway
(Kolb & Whishaw, 2015). The nigrostriatal pathway shuttles dopamine to the dorsal
striatum, where it helps maintain normal motor control. The mesolimbic pathway carries
dopamine to the nucleus accumbens and the prefrontal cortex. The nucleus accumbens is
crucial to the reward system of the brain and motivation. The prefrontal cortex is
responsible for complex cognitive functions such as planning, decision making, and
social behavior. Decreases in dopamine availability in the mesolimbic pathway have been
hypothesized to be the cause of deficits in decision-making, motivation, and
reinforcement processes in ADHD (Sonuga-Barke, 2005; Volkow et al., 2009). Similar to
studies showing reduced grey matter in adolescents with ADHD, slower development and
pruning of neuronal pathways to the caudate nucleus (within the basal ganglia) was also
observed in the brains of adolescents with ADHD. These differences disappeared or were
negligible by the time these adolescents reached early adulthood (Rubia et al., 2014; Silk
et al., 2009;).
The existing body of research into brain structure and function in ADHD is
somewhat limited by small sample sizes, but interest continues to grow in imaging
studies as a way to better understand the disorder (Rubia et al., 2014). ADHD is
associated with structural and functional differences from typically developing brains in
the frontal lobe, striatum, basal ganglia, and dopaminergic systems is associated with
ADHD (Fassbender et al., 2015; Rubia et al., 2014; Shaw et al., 2007; Solanto et al.,
2009; Sonuga-Barke, 2005; Volkow et al., 2009; Wiers et al., 2018).
Genetics of ADHD Genetic studies have found polymorphisms in genes
responsible for encoding proteins of the dopamine transporter (DAT1) and the dopamine
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receptors (D2 and D3) to be related to ADHD (Wiers et al., 2018). These proteins are
responsible for dopamine reuptake from the synaptic cleft and uptake of dopamine into
the postsynaptic neuron (Volkow et al., 2009). Stimulant medications prescribed for
ADHD are thought to be effective because they work to increase the availability of
dopamine in the synaptic cleft (Weirs et al., 2018). Studies have shown that higher levels
of DAT1 available in the striatum are associated with better treatment response to
stimulant medications in adults with ADHD (Krause, 2008).
The alleles associated with ADHD are commonly found in the general population
and, therefore, lack the specificity necessary to represent a “biomarker” for ADHD. One
line of research has explored epigenetic markers that could explain the interaction
between genes and environment that impacts dopaminergic processes in ADHD.
Epigenetic studies have found the methylation or expression of DAT1 gene in blood cells
is associated with DAT availability in the striatum and substantia nigra as measured by
positron emission tomography, and tissue and blood samples taken during postmortem
autopsies of primate brains and the brains of humans with ADHD (Rajala et al., 2014;
Weirs, 2018).
Brain changes in response to medication and psychotherapeutic treatment.
Researchers use brain imaging techniques to examine changes in the structure of the
brain as a way to measure treatment outcomes for psychotherapy and medications. These
studies generally measure brain changes through prettreatment and posttreatment imaging
or examining the relationship between pretreatment imaging and posttreatment measures
of response to treatment. The efficacy of treatments for a wide variety of psychological
disorders, including ADHD, has been investigated using these methods (Weingarten &
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Strauman, 2015). Imaging studies of brains before and after receiving psychotherapeutic
interventions or prolonged psychostimulant use have observed a normalizing effect,
whereas the brains of those with ADHD become more similar to the brains of typically
developing individuals.
For example, one study examined the efficacy of a “summer camp” style token
economy program for children with ADHD. ADHD and control children without ADHD
had functional MRI images taken during a go/no-go task before and after living and
participating in the activities of the behavioral treatment program for ten days. Control
children’s inhibition greatly improved post treatment, but the ADHD children’s
performance did not significantly improve. The functional MRI images (fMRI) taken
during the pretreatment administration of the go/no-go task revealed activation of the
anterior cingulate cortex, right caudate nucleus, and dorsal lateral pre frontal cortex
(DLPFC) bilaterally in both groups. However, activation in these areas pretreatment was
higher in the controls compared to the ADHD group. Posttreatment, the between groups
differences in fMRI brain activation in these regions were nonsignificant, with the
ADHD children showing only slight, nonsignificant improvement in reaction time
variability (a measure of basic attention) from pretreatment levels (Siniatchkin et al.,
2012).
In another study, adults with ADHD who received 12 weekly sessions of CBT
demonstrated improvements in brain connectivity and reduction in ADHD
symptomatology. MRI imaging following treatment observed increased functional
connectivity between the frontal-parietal network, the cerebellum and superior parietal
lobule, as well as decreased self-reported ADHD symptoms. Increased bilateral
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connectivity in the superior parietal lobule was significantly and negatively correlated
with ADHD symptoms severity, indicating impaired connectivity in the superior parietal
lobule may play a key role in ADHD and its amelioration (Wang et al., 2016).
Imaging studies examining the effect of psychostimulants on those with ADHD
consistently find that stimulant use alters the structure and function of the brain. A
literature review found 29 published imaging studies on changes to the structure and
function of the brain in ADHD related to stimulant medication use. All studies examining
structural differences between unmedicated participants with ADHD and control groups
without ADHD found structural abnormalities in the brains of those with ADHD.
Stimulant medication use was associated with attenuation of these structural
abnormalities in many of the brain regions examined. The most consistent finding
between these studies found stimulant use to treat ADHD was associated with greater
volume of white matter in all lobes of the brain, and grey matter in the anterior cingulate
cortex and splenium of the corpus callosum (Spencer et al., 2013). The majority of the
functional imaging studies found that participants with ADHD demonstrate less
activation in the striatum (including caudate and putamen), anterior cingulate cortex, and
prefrontal cortex when subjected to tasks that require prolonged use of attention,
executive functioning, or emotion regulation. These structural differences in the brains of
those with ADHD were negligible from control groups following prolonged treatment
with stimulant medications (Spencer et al., 2013).
Research into brain changes following interventions for ADHD demonstrated that
those with ADHD exhibit less activation of the regions of the brain and neural networks
involving attention, working memory, sensory integration and dopamine production. This
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reduced activation can be ameliorated by evidence based-psychotherapy and treatment
with stimulant medication, however these functional improvements do not always lead
directly to improved ADHD symptomatology (Siniatchkin et al., 2012; Spencer et al.,
2013; Wang et al., 2015).
Neuropsychological Functioning in SCT and ADHD
Although slow or inefficient cognitive abilities is considered one of the key
features of SCT, research has produced mixed results when examining the relationship
between SCT and various measures of cognitive abilities (Bauermeister et al., 2012;
Becker & Barkley, 2018). Researchers have compartmentalized and operationalized
cognitive abilities into a variety of domains such as executive functioning, working
memory, and processing speed. Poor performance on measures of these constructs
indicates that an individual’s cognitive functions are notably slower or inefficient
compared to the general population. This cognitive impairment is attributed to structural
and functional differences in the brain that alters the way it functions compared to
typically developing individuals.
Facets of cognitive functioning such as learning, working memory, processing
speed, attention, visual-spatial skills, motor coordination, and verbal reasoning are
believed to be localized to specific regions of the brain. Complex collaboration among
these interdependent regions enables the brain to produce the sophisticated behaviors and
thoughts that make up the human experience. Dysfunction or injury in one or more of
these regions interrupts these interdependent processes and can influence or impair one’s
cognitive or behavioral functioning (Lezak et al., 2012). Thus, brain imaging technology
can offer detailed images of alterations to the structure and function of the brain that
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illuminate the neurological substrates of ADHD and explain some neuropsychological
functioning.
Neuropsychological tests offer ways to measure broad concepts such as general
intelligence or specific cognitive processes. One of the most widely accepted
neuropsychological batteries is the Wechsler Adult Intelligence Scale - Fourth Edition
(WAIS-IV). Completion of the standard test battery on the WAIS-IV produces a score of
general intelligence and index scores representing the strength of processing speed,
working memory, verbal ability, and perceptual reasoning compared to an age matched
population sample.
A variety of neuropsychological measures exist that infer impairment in cognitive
functioning through observation of an individual’s performance on a task (Lezak et al.,
2012). A meta-analysis of studies comparing participants with ADHD and control groups
found performance on several neuropsychological measures to differ significantly.
Specifically, the participants with ADHD consistently performed worse on the Trails A
and Trails B test, which are neuropsychological measures of processing speed and
executive functioning, respectively (Hervey et al., 2004; Reitan, 1993). Their
performances on the digit span, digit symbol coding (Coding task), and arithmetic tests
from the WAIS (measuring processing speed and working memory) were significantly
worse with ADHD than the control groups’ (Hervey et al., 2004; Wechsler, 2008;).
These neuropsychological measures of executive functioning, processing speed,
and working memory held large to medium weighted effect sizes (Hervey et al., 2004).
Whereas these particular measures held substantial effect sizes across studies, many other
neuropsychological measures of working memory, processing speed, and executive
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functioning had negligible findings across these studies. This pattern of inconsistent
findings across neuropsychological measures that purportedly measure the same
cognitive function was true for measures of attention, memory, and motor speed as well.
These findings indicate that no single cognitive function is attributable to ADHD. Rather,
those with ADHD exhibit widespread neuropsychological deficits and variability in
multiple domains of cognitive functioning (Hervey et al., 2004).
SCT and Neuropsychological Functioning
There is a dearth of studies examining the relationships between SCT and
measures of working memory and processing speed (Jacobson et al., 2018). One study
examined children and adolescents with ADHD-IN and typically developing children and
adolescents. Parents’ ratings of their children’s SCT symptoms and the participants’
processing speed index (PSI) scores on the Wechsler Intelligence Scale for Children were
used in this analysis. All participants’ SCT ratings were factor analyzed, producing three
factors consistent with the sleepy/sluggish, daydreamy, and low initiation symptom
domains of SCT. The day dreamy and low initiation factors were significantly inversely
associated with PSI scores with a small effect size, indicating SCT symptoms partially
reflect “sluggishness” in their cognitive processes (Jacobson et al., 2018).
A study of SCT and ADHD in Puerto Rican children utilized mothers’ and
teachers’ collateral report ratings of the participants’ behavior and ADHD
symptomatology and neuropsychological measures. The authors combined multiple
collateral report and neuropsychological measures of behavior and cognitive functioning
into composite scores that represented the participant’s ability in different cognitive
domains. These composite scores included measures of working memory, processing
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speed, memory retrieval, interference control, and planning/problem solving. Separate
confirmatory factor analyses were conducted for the teacher ratings and parent ratings of
ADHD and SCT symptomatology to confirm the parent rating were accurately reflecting
the inattentive, hyperactive/impulsive, and SCT domains of ADHD. Contrary to
expectations, SCT was not associated with any of the collateral reports of cognitive
functioning or executive functioning measures (Bauermeister et al., 2012). On the other
hand, strong associations were found between ADHD-In symptoms and many of the
cognitive functioning measures used. The authors acknowledged these relationships
between inattention and cognitive functioning were not controlled for in the analyses, and
may have overshadowed SCT’s relationships with the cognitive functioning measures
(Bauermeister et al., 2012).
Another cause for these disparate findings may be in the types of measures used
to create the composite scores. The working memory composite was derived from
neuropsychological measures of verbal working memory for numeric information,
nonverbal working memory for spatial information, and nonverbal working memory for
motor sequencing. In a similar way, the processing speed composite was derived from
neuropsychological measures of rapid naming of stimuli, speeded motor, and
nonlinguistic processing speed. It is possible SCT’s lack of associations with the
processing speed and working memory composites is due to the measures used to build
these composites examining different loosely related functions rather than representing
one uniform cognitive function (Bauermeister et al., 2012).
Kamradt et al. investigated the differences between adults with minimal,
moderate, or severe levels of SCT in their anxiety, internalizing symptoms, and
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externalizing symptoms. They also compared these groups on their performance on
measures from a battery of neuropsychological tests. The three groups did not differ in
their performance on measures of inhibition, interference control, vigilance, or sustained
attention. Only those in the moderate SCT group exhibited significantly worse working
memory (measured by performance on the WAIS-IV Digit Span task) compared to both
the severe and mild SCT groups. This finding is unusual because it implies a parabolic
relationship between SCT and working memory. One explanation for this finding put
forth by the study’s authors suggests that those with moderate SCT may be at particular
risk for working memory impairment due to subtle diffuse neuropsychological
impairment culminating to impair working memory (Kamradt et al., 2018).
Utility of Neuropsychological Testing for ADHD and SCT
The extant literature demonstrates inconsistency in the relationships between both
ADHD and SCT and a variety of neuropsychological measures, especially those of
working memory and processing speed. Although standardized neuropsychological
measures are generally considered crucial to accurately measure cognitive functions, the
validity of neuropsychological testing for diagnosing of ADHD has been called in to
question. Prior research has found between 35% and 87% of those who meet DSM
criteria for ADHD show no impairment on neuropsychological measures. As a result, the
false negative rate of most neuropsychological measures is too high to be used as a
diagnostic measure for ADHD (Barkley, 2019; Matier-Sharma et al., 1995; Ramsay,
2015). Clinicians advocating for best practices in the diagnosis of ADHD and SCT argue
that clinical interviews and self-report measures of executive functioning are more
ecologically valid tools for identifying the difficulties those with ADHD and SCT face
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and have better predictive power (Barkley, 2011b, 2019; Barkley & Fischer, 2011;
Pettersson et al., 2018). Although neuropsychological measures may not be the best way
to diagnose ADHD in adults, these measures still provide valuable information on
cognitive deficits, language issues, effort, and other potential issues that can affect
learning and occupational functions and may, therefore, be more useful for identifying
deficits and treatment planning, than diagnosis alone (Mapou, 2019).
Executive Functioning
Researchers examining the construct of executive functioning have defined it in
different but closely related ways. Conceptualizations of executive functioning have
attributed a variety of cognitive processes and abilities to executive functioning including
goal-directedness, time management, hindsight, self-consciousness, inhibition,
motivation, problem solving, interference control, and cognitive flexibility. As previously
mentioned, executive functioning is a set of top-down mental abilities that requires the
collaboration of different cognitive and neuropsychological processes. These processes
work together to help an individual monitor and regulate behavior over time towards the
achievement of a goal or to solve a novel problem. In other words, executive functioning
determines how effective one is at accomplishing what they set out to do. (Barkley,
2011b; Diamond, 2013). Core aspects of executive functioning recognized by the
National Institutes of Health are inhibition (self-control and resisting the urge to act
impulsively), interference control (selective attention and cognitive inhibition), working
memory, and cognitive flexibility (creative thinking and quickly and flexibly adapting to
changing circumstances; Diamond, 2013).
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Executive functioning deficits have been implicated in a variety of mental health
disorders including addiction, conduct disorder, depression, obsessive compulsive
disorder, schizophrenia, and ADHD. Executive functioning deficits have also been
observed to be associated with social and physiological problems including obesity,
school performance, vocational success, marital discord, and even criminal behavior
across multiple studies and populations (Diamond, 2013). Different patterns of executive
functioning have been found to differently associate with both ADHD and SCT in adults
(Barkley, 2011b, 2011c, 2012; Willcutt et al., 2005).
The Barkley Deficits in Executive Functioning Scale (BDEFS) is a self- and
other-report behavior rating scale developed to measure deficits in specific executive
functioning domains and overall executive functioning in adults (Barkley, 2011b). These
domains include self-management to time, self-organization/problem-solving, selfrestraint, self-motivation, and self-regulation of emotion (Barkley, 2011b). The BDEFS
domains are functionally different from neuropsychological measures of executive
functioning because it assesses how dysfunction in executive functioning causes
problems in everyday life over the past six months. Neuropsychological measures of
executive functioning indicate how individuals perform on an executive functioning task
in a controlled setting, typically for no longer than 30 minutes and may, thus, lack the
external validity found in the BDEFS. Nonetheless, all BDEFS domains were largely
found to be mildly to moderately correlated with several neuropsychological measures of
cognitive functioning such as the Digit Span task from the WAIS-III, Conners’
continuous performance task, and Stroop color word task (Barkley, 2011b; Smith et al.,
2013).
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The BDEFS domains were largely unrelated to measures of intelligence or
academic achievement, with the exception of the deficits in self-organization/problemsolving domain holding a weak negative relationship with full scale IQ on the WAIS-IV
(Barkley, 2011b). Preliminary research on the BDEFS found significantly more adults
with ADHD rated themselves as having clinical levels of impairment in executive
functioning than a clinical control group and a community control group (Barkley,
2011b). In another test comparing executive functioning tests and rating scales, the
BDEFS and other tests of executive functioning were administered to adults with ADHD,
adults who had ADHD in childhood that remitted in adulthood, and individuals who
never exhibited symptoms of ADHD. Of these measures of executive functions, only the
five subscales of the BDEFS were sensitive to differences between those with current
ADHD from those whose symptoms remitted after childhood (Barkley, 2011b). These
findings indicate the BDEFS holds good construct and discriminant validity, and is an
ecologically valid measure of executive functioning deficits (Barkley 2011b, 2019).
Executive Functioning in ADHD and SCT
Barkley examined the differences in executive functioning between ADHD and
SCT by comparing subscale scores on the BDEFS of groups of adults with ADHD only,
SCT only, both ADHD and SCT, and a control group. The SCT-only group and the
ADHD and SCT group both reported worse self-organization and problem solving
abilities than the control or ADHD-only group. The combined ADHD and SCT group
scored the lowest on the subscales of self-management to time, self-restraint, selfmotivation, and self-regulation of emotion (Barkley, 2012). Stepwise regression analysis
examined how much the participant’s symptom ratings of SCT, ADHD-In, and ADHD-
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H/I contributed to the variance in executive functioning subscale scores. SCT symptoms
contributed the most variance in Self-Organization and Problem-Solving (54.5%), SelfDiscipline (45.8%), and Self-Regulation of Emotion (44.5%), with ADHD-IN explaining
less than 9% of the variance for each. ADHD-In symptoms contributed the most variance
to Self-Management to (54.5%) and Self-Motivation (48.8%) with SCT symptoms
explaining less than 5% of the variance for each (Barkley, 2012).
One study utilizing a nonclinical sample of college students explored the
relationship between SCT scores on the BAARS-IV, executive functioning scores on the
BDEFS, study skills, and general functional impairment. Path analyses were conducted to
control for the influence of demographic information, anxiety, and depression, and
ADHD symptoms on the relationships between SCT, executive functioning, study skills,
and general functional impairment. SCT remained significantly associated with executive
functioning deficits, poorer study skills, and general functional impairment. Two
regression models examined the relative contribution of anxious, depressive, SCT, and
ADHD symptoms as well as demographic information in predicting executive
dysfunction. These analyses found that adding SCT to the model reduced the association
between depressive symptoms and executive functioning to nonsignificance. Moreover,
adding SCT to the model dramatically reduced the relationship between ADHD-In
symptoms and executive functioning. In fact, SCT emerged as the strongest predictor of
executive functioning deficits and added an additional 6% to the variance in executive
functioning (Flannery et al., 2017).
The previously mentioned study by Leikauf and Solanto (2017) examined
differences in relationships between SCT, ADHD symptoms, and a measure of executive
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functioning in medicated and unmedicated adults with ADHD. They used self-report
form of the BDEFS to measure executive functioning, self-report form of the BAARS-IV
to measure SCT, the STAI and BDI-II to measure depression, and the Conners Adult
ADHD Rating Scale-Self-Report (CAARS) to measure ADHD symptoms. In
unmedicated participants, strong and significant correlations were observed between SCT
scores and the BDEFS Summary score as well as between ADHD symptoms and the
BDEFS Summary score. However, in the medicated group ADHD symptoms were not
significantly correlated with the BDEFS Summary score. Only the self-restraint score
was significant for those taking stimulant medications. SCT was a better predictor of
overall executive functioning impairment, “above and beyond,” ADHD or depression for
both medicated and unmediated participants. These results seem to imply that, when
ADHD symptomatology was reduced or managed by stimulant medication, the
relationship between SCT and executive functioning persisted (Leikauf & Solanto, 2017).
In studies using the BDEFS to examine executive functioning’s relationships with
SCT and ADHD, SCT was found to be a significant predictor of deficits in all executive
functioning domains on the BDEFS, even when controlling for confounding factors such
as ADHD, internalizing symptoms, and demographic information (Jarrett et al., 2017;
Leikauf & Solanto, 2017). These findings indicate that the BDEFS is a good measure of
executive functioning impairment in those with both ADHD and SCT.
These studies demonstrate inconsistency and complexity in the relationships of
ADHD and SCT to a variety of measures of neuropsychological and cognitive
functioning, including measures of executive functioning, working memory, and
processing speed. However, some measures of these constructs have demonstrated more
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consistent relationships with SCT and ADHD than others. A meta-analysis of
neuropsychological measures’ relationships with ADHD by Hervey et al., found the
subtests from the processing speed index and working memory index of the WAIS-IV
consistently demonstrated significant large effect sizes in its associations with ADHD.
The executive functioning domains measured by the BDEFS consistently demonstrated
unique and independent relationships with ADHD and SCT symptomatology (Barkley,
2011b; Barkley, 2012; Flannery et al., 2017; Jarrett et al., 2017; Leikauf & Solanto 2017).
These relationships are independent the association of SCT with classic ADHD
symptomatology, and in some studies, SCT was a greater predictor of cognitive
functioning than ADHD symptoms. According to Leikauf and Solanto (2017), “overall,
these results demonstrate that SCT in adults is not exclusively a proxy for ADHD
symptom severity or internalizing symptomatology” (p. 709), but rather represents its
own syndrome that predict deficits in cognitive functioning.
Summary of Literature Review
SCT and ADHD are two highly related disorders that co-occur in 46% of all cases
of ADHD and 54% of all cases of SCT (Barkley, 2012). SCT symptomatology shares
many features with the inattentive subtype of ADHD, but extensive testing has
demonstrated that these disorders are distinct from one another (Barkley, 2011a, 2012;
Becker et al., 2016; Becker & Barkley, 2018; Becker, Marshall, & McBurnett, 2014;
Garner et al., 2010; Wåhlstedt & Bohlin, 2010).
SCT scores are, independently of ADHD symptoms, associated with impairment
in social, academic, and emotional functioning (Becker & Barkley, 2018). SCT was also
associated with internalizing symptoms, such as depression and anxiety, when controlling
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for ADHD symptomatology (Bauermeister et al., 2012; Becker, Langberg, et al., 2014;
Carlson & Mann, 2002; Kamradt et al., 2018). In some instances, SCT held stronger
relationships with internalizing symptomatologythan ADHD (Becker, Langberg, et al.,
2014). This relationship between SCT and internalizing disorders may be due to shared
features of these disorders such as apathy, rumination/daydreaming, inactivity, and
decreased effort (Smith & Langberg, 2017). High levels of effortful control and low
stress levels are protective factors against internalizing disorders (Gulley, et al., 2017).
Both ADHD and SCT have been shown to be associated with impairment in a
variety of neuropsychological and cognitive domains, such as executive functioning,
working memory, processing speed, attention, and memory. However, these relationships
are inconsistent and vary in significance and effect size from study to study
(Bauermeister et al., 2012; Hervey et al., 2004; Jacobson et al., 2018; Kamradt et al.,
2018). This is possibly due to the limited utility of neuropsychological measures in these
populations and diffuse deficits across multiple neuropsychological and cognitive
domains in both ADHD and SCT (Barkley, 2019; Hervey et al., 2004; Mapou, 2019).
Hypothetical Models of SCT
The process model of depletion argues that an individual’s self-control wanes as
their motivation and attention shifts away from goal directed behavior (Inzlicht &
Schmeichel, 2012). External manipulations of motivation have been shown to reduce the
impairment in basic attention in those with ADHD, as posited by this model (Dekkers et
al., 2017; Inzlicht & Schmeichel, 2012). Second, conceptualization of ADHD and SCT in
Posner’s model of attention argues that SCT is characterized by deficits in the orienting
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stage of attention, whereas ADHD is the product of deficits in the alerting, orienting, and
executive functioning aspects of attention (Barkley, 2016; Becker & Willcutt, 2018).
In light of these two theories and research on the relationships between ADHD
and SCT, SCT symptomatology may be the product of interactions between internalizing
symptomatology and impaired cognitive functioning. Consider the case of a hypothetical
individual who experiences impairment in working memory and processing speed, with
comorbid internalizing symptoms. When a situation or task that requires mental effort
arises, their impaired cognitive functions are already taxed by internalizing
symptomatology, reducing their capacity to orient to the new situation and decreasing
their motivation to expend further effort to engage with the new situation or fully exercise
their executive functions. Internalizing symptoms such as anxiety, depression, somatic
complaints, and traumatic stress may lead to rumination (daydreaming about negative
emotional experiences) and require sustained effort to cope with the negative aspects of
these symptoms. These consequences are reflected in the day dreamy and low initiation
aspects of SCT (Jacobson et al., 2018). Following this logic, SCT may be better
conceptualized as a transdiagnostic factor that is present in individuals with
neuropsychological impairments or a separate neurodevelopmental disorder in its own
right.
SCT could also be conceptualized as a syndrome whose symptoms reflect deficits
in executive functions and the internalization of these challenges. The theory of TDFs
posits that underlying mental health problems express themselves as different mental
health disorders with different symptoms according to an individual’s personal
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characteristics and life experiences. A commonly accepted TDF paradigm is the
internalization or externalization of negative affect (Krueger & Eaton, 2015).
Multiple researchers have proposed that deficits in a specific executive function
or broad deficits in executive functioning are the source of the inattentive, hyperactive,
and impulsive symptoms of ADHD (Willcutt et al., 2005). A study of SCT and ADHD
found SCT contributed the majority of the variance to the Self-Organization and
Problem-Solving, Self-Discipline, and Self-Regulation of Emotion subscales of the
BDEFS , whereas inattentive symptoms of ADHD explained less than 9% of the variance
for each. Inattentive symptoms explained the majority of the variance for the remaining
Self-Management and Self-Motivation subscales, whereas SCT explained less than 5% of
the variance for each (Barkley, 2012). Perhaps deficits in these or other specific executive
functions are also the source of the symptoms of SCT.
Considering SCT and executive dysfunction in the context of internalization of
mental health challenges, it is theoretically possible that SCT represents a novel
internalizing expression of executive dysfunction. The hyperactive and impulsive
symptoms of ADHD may reflect an externalization of executive dysfunction or
inhibition, whereas the inattentive symptoms could reflect an internalization of executive
dysfunction or inhibition. If an individual is experiencing executive dysfunction in
organization, self-discipline, or emotion regulation and they have a tendency to
internalize their problems, their unique blend of personal characteristics and life
experiences may result in SCT symptomatology. This could also partially explain SCT’s
strong relationships with internalizing symptoms. An internalizing disorder such as
depression reflects the internalization of negative affect. In the same way, SCT may
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reflect internalization of executive dysfunction. An individual who has a tendency to
internalize their problems would be more likely to develop an internalizing mood
disorder, such as depression, and internalize their executive dysfunction, which could be
expressed as SCT.
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Chapter 3: Method
The study examined the relationships between SCT, ADHD, cognitive
functioning, and internalizing symptoms in adults diagnosed with ADHD, employing a
combined cross-sectional between subjects design and correlational/regression design
using existing data.
Participants
This study utilized existing data collected from 143 adult subjects who have
previously received a psychological assessment at a university-based, adult ADHD
outpatient specialty clinic in a large urban area located in the Northeastern United States.
Inclusion and Exclusion Criteria
This study examined existing data. Subjects were those 18 years old or older
assessed at intake by clinician rating to meet the full symptom criteria for the Inattentive,
Hyperactive/Impulsive, or Combined subtype of ADHD, as well as those who meet
criteria for SCT. ADHD criteria were established by the Conners Adult ADHD Rating
Scale - Self-Report (CAARS), and clinician ratings on the Structured Clinical Interview
for DSM-5 Disorders (SCID-5). SCT criteria were established by the SCT subscale of the
BAARS-IV.
Individuals diagnosed with severe psychiatric issues, such as a co-occurring
psychotic disorder and severe current substance use disorders, as established by the
SCID-5 administered as part of the psychological assessment, clinician rating, or
previous diagnosis, were excluded from the study. Of the 143 subjects, only three met
criteria for moderate substance use disorders. Substance use disorders have been
identified as commonly occurring in individuals with ADHD (Zulauf, Sprich, Safren, &
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Wilens, 2014). These individuals were retained for the analyses because vulnerability to
substance use disorders is an important part of the ADHD profile.
Measures of ADHD and SCT Symptoms
Barkley Adult ADHD Rating Scales-Fourth Edition (BAARS-IV)
The BAARS-IV is a 27 item scale, available in self- and other-report rating
versions, designed to measure the symptoms of ADHD (Barkley, 2011a). The items are
organized into four subscales: three that correspond with the DSM-IV inattentive,
impulsive, and hyperactive symptoms of ADHD, and a fourth that measures the
symptoms of SCT. Scores on the inattentive and SCT subscales can range from 9 to 36,
with higher scores indicating greater levels of symptomatology. Scores on the
hyperactive subscale range from 5 to 20. Scores on the impulsive subscale range from 4
to 16. Higher scores on a subscale of the BAARS-IV reflect a greater number and/or
magnitude of endorsed symptoms of ADHD or SCT. Participants and an informant of
their choice are asked to rate the frequency with which the participant engages in or
experiences each of the symptoms of ADHD or SCT from 1 (never or rarely) to 4 (very
often).
Subjects’ responses on the four BAARS-IV subscales are summed to create a total
raw score for each subscale. The raw score is used to calculate a statistic reflecting each
subject’s percentile rank compared to others in the same age group for each symptom
domain. A subject’s percentile score represents the portion of individuals in the
normative sample the individual scored higher than on the subscale. Scores in the 93rd
percentile or higher reach clinically significant levels of the symptom domain and
indicate the presence of ADHD or SCT (Barkley, 2011a).
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The BAARS-IV subscales were used to operationalize ADHD and SCT in two
ways. Analyses examining ADHD and SCT symptoms from a continuous perspective
used subjects’ percentile ranks for each symptom domain. Analyses that conceptualized
ADHD symptom domains and SCT from a categorical perspective will use the 93rd
percentile score on each symptom domain as a cutoff score for identifying clinically
notable levels of the symptom domain (Barkley, 2011a, 2012). The BAARS-IV subscales
were found to have satisfactory internal consistency (Cronbach’s α ranged from 0.776 to
0.914) and test-retest reliability (0.66-0.76; Barkley, 2011a). Further testing of the
BAARS-IV using Widaman’s (1985) method supported convergent validity with a DSMIV checklist of childhood ADHD (X2 = 903.0, p < 0.001) and discriminant validity
between self and informant forms of the BAARS-IV (X2= 1166.9, p = 0.01) using
multitrait multimethod approach (Leopold et al., 2015).
Conners Adult ADHD Rating Scale - Self-Report (CAARS)
The CAARS is a 66-item self-report measure designed to examine the symptoms
of ADHD in adults. Participants respond to each item by rating themselves from 0 (not at
all, never) to 3 (very much, very frequently) based on their level of agreement with each
item or their reported frequency of the behavior described by each item. The items on the
CAARS contribute to four scales, that measure common symptoms of ADHD, as well as
three scales that reflect the DSM-IV symptom criteria for ADHD. The DSM-IV
Inattentive Symptoms subscale and DSM-IV Hyperactive/Impulsive Symptoms subscale
were used as continuous measures to operationalize the symptoms of ADHD. This
allowed for the severity of the subjects’ inattentive and hyperactive/impulsive
symptomatology to be measured continuously rather than merely identifying whether or
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not they meet criteria for an ADHD diagnosis. Scores on the DSM-IV Inattentive
Symptoms subscale and IV Hyperactive-Impulsive Symptoms subscale range from 0 to
27, with higher scores indicating higher levels of ADHD symptomatology. The raw
subscale scores are converted to T scores, with a T score of 65 or greater indicating
clinically notable levels of the symptoms domain. The DSM-IV Inattentive Symptoms
subscale and IV Hyperactive-Impulsive Symptoms subscale of the CAARS have been
found to have excellent discriminant validity; comparison study of adults who met DSM
criteria for ADHD and an age- and gender-matched control group who did not meet DSM
criteria for ADHD found these subscales had an 85% correct classification rate (Conners
et al., 1999).
Measures of Internalizing Symptoms
Internalizing symptoms are operationally defined as scores on the BDI-II, Penn
State Worry Questionnaire (PSWQ), the Affect subscale of the BADDS, and Neuroticism
scale of the NEO-PI-R. In several studies, these measures of internalizing symptoms have
demonstrated good convergent validity, with significant moderate relationships among
them. In a prior study using data from the same university-based adult ADHD outpatient
specialty clinic, the Neuroticism scale of the NEO-PI-R had good convergent validity
with the PSWQ (R2 = 0.294, p < 0.08) and the BDI-II (R2 = 0.343, p < 0.08; Serine,
2016). The Neuroticism scale has also been found to be associated with difficulty
regulating emotions as measured by the Affect scale of the BADDS (R2 = 0.388, p <
0.001; Di Nicola et al., 2014). In a study of internalizing symptoms a sample of
Caucasian and African American adults, scores from the BDI-II were significantly related

ADULTS WITH ADHD AND SLUGGISH COGNITIVE TEMPO

54

to scores on the PSWQ (R2 = 0.30, p < 0.01; Chapman, Kertz, & Woodruff-Borden,
2009).
Brown Attention Deficit Disorder Scale - Adult Version (BADDS)
The BADDS is a 40-item self-report scale designed to screen for common
difficulties and core features of the Inattentive symptoms of ADHD, based on the
executive dysfunction model of ADHD (Brown, 1996; Brown & Whiteside, 2003). The
BADDS is unique among measures of adult ADHD in that it identifies both ADHD
symptomatology and signs of executive dysfunction that those with ADHD sometimes
face. Each item on the BADDS describes a problem or symptom associated with ADHD.
Participants rate how much each item has been a problem for them in the past 6 months
from 0 (never) to 3 (almost every day). Each item on the BADDS contributes to a total
score as well as one of five subscale scores, which measure difficulty (a) activating or
organizing for work, (b) sustaining attention , (c) sustaining mental effort on boring or
difficult tasks, (d) managing affect and emotion that could interfere with work, and (e)
problems with working memory or recall. Only the affect subscale of the BADDS
(BADDS-Affect) was used in these analyses as a measure of participants’ capacity to
regulate their internalizing symptoms in the analyses. Raw scores on the BADDS-Affect
can range from 0 to 21. This score is converted to a T score, with T scores of 65 or
greater indicating clinically notable levels of difficulty managing affect and emotion The
BADDS has demonstrated satisfactory test-retest reliability (r = 0.87) and excellent
internal consistency (Cronbach’s α = 0.96; Brown & Whiteside, 2003). The Affect
subscale has demonstrated good convergent validity with the Internalizing problems
subscale of the Behavior Assessment System for Children (R2 = 0.52), and the Emotional
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Control subscale of the Behavior Rating Scale of Executive Function (R2 = 0.66; Brown,
1996).
Penn State Worry Questionnaire (PSWQ)
The PSWQ is a self-report measure designed to measure the severity of worry
(Meyer et al., 1990). Participants respond to a series of 16 items on their tendency to
worry, rating the statements from 1 (not at all typical of me) to 5 (very typical of me).
Five of the items are reverse scored. Scores on the PSWQ range from 16 to 80. Higher
total scores represent greater frequency and severity of worry. The PSWQ was used to
measure the anxiety and worry component of internalizing symptoms in the planned
analyses. Individuals with ADHD may underreport their level of impairment on selfreport measures due to a lack of self-awareness on their behavior (Manor et al., 2012). By
focusing on worry rather than other behavioral features of anxiety, the PSWQ has higher
construct validity for those with ADHD than other measures of anxiety (Meyer et al.,
1990). The PSWQ has demonstrated good internal consistency (Cronbach’s α = .83-.93)
and test-retest reliability (r = .74-.93) (Brown et al., 1992; Molina & Borkovec, 1994).
The PSWQ has demonstrated good discriminant validity and captures features of
generalized anxiety such as the apprehensive and uneasy symptoms of anxiety often
expressed by those with co-occurring anxiety and ADHD (Meyer et al., 1990; Ramsay,
2015).
Beck Depression Inventory, Second Edition (BDI-II)
The BDI-II is a 21-item self-report measure designed to assess severity of
depression (Beck et al., 1996). Participants rate the severity of their depression by
endorsing different statements grouped by key symptoms of depression such as sadness,
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self-dislike, social withdraw, loss of appetite, irritability, feelings of guilt, suicidality, and
anhedonia. These statements are rated from 0 to 3 and summed to create a total score.
Scores on the BDI-II range from 0 to 63. Higher scores on the BDI-II represent more
severe symptoms of depression. The BDI-II has demonstrated high internal consistency
(Cronbach’s α = .91) and test-retest reliability (r = .93) (Beck et al., 1996). Further testing
of the BDI-II found it demonstrates moderate to high convergent validity with the Short
Form General Health Survey (R2 = 0.42, p < 0.01; Arnau et al., 2001).
Revised NEO Personality Inventory (NEO-PI-R)
The NEO-PI-R is a 240-item measure of the five personality domains in the five
factor model of personality: Neuroticism, Openness, Extraversion, Agreeableness, and
Conscientiousness. Items on the NEO-PI-R consist of statements about oneself that are
rated on a Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree). These
items each contribute to subscale score reflecting one of the five personality domains.
Scores on each subscale range from 0 to 192. These raw scores are converted to
standardized T scores. T scores greater than 65 are in the very high range. T scores
between 55 and 65 are in the high range. T scores between 45 and 55 are in the average
range. T scores between 35 and 45 are in the low range. T scores below 35 are in the very
low range (Costa & McCrae, 1992; Serine 2016). Internalizing behavior was assessed
using the personality factor of neuroticismbecause it reflects symptoms of anxiety and
depression as well as personality traits related to internalizing symptoms, such as selfconsciousness and feelings of vulnerability.
Research on use of the NEO-PI-R in those with ADHD has found high
neuroticism, low agreeableness, and low conscientiousness are common personality traits
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shared among this population (Parker et al., 2004). The chronic restlessness and higher
levels of physiological arousal characteristic of hyperactive symptoms of ADHD can be
mistaken for anxiety by some measures (Meyer et al., 1990; Ramsay, 2015). The NEOPI-R measures stable personality traits and the cognitive aspects of anxiety and other
internalizing symptoms (Costa & McCrae, 1992). This allows it to measure internalizing
symptomatology, without being overly influenced by confounding physiological
symptoms of hyperactivity. Multiple studies have demonstrated that the personality
domains of the NEO-PI-R hold excellent convergent validity with other well established
measures of similar personality traits. This includes the relationship between NEO-PI-R
Extraversion and the Extroversion scale of the Myers Briggs Type Indicator (R2 = 0.55),
NEO-PI-R Neuroticism and the Succorance scale of the Adjective Checklist (R2 = 0.36),
and NEO-PI-R Conscientiousness and the Endurance scale of the Adjective checklist
(R2 = 0.28; Costa & McCrae, 1992). The NEO-PI-R has also demonstrated good testretest reliability (r = 0.52 to 0.81) and interrater reliability (r = 0.86 to 0.95) across
multiple studies (Costa & McCrae, 1992).
Measures of Cognitive Functioning
Cognitive functioning was operationally defined as subjects’ performance on the
Coding task and Digit Span task of the WAIS-IV, and their Total Executive Functioning
summary score of the BDEFS. These measures of cognitive functioning have
demonstrated good convergent validity with one another, with small to moderate
significant correlations ranging from .15 to .52 (Barkley 2011b; Wechsler, 2008).
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Barkley Deficits in Executive Functioning Scale (BDEFS)
The BDEFS is a behavior rating scale developed to measure deficits in executive
functioning in adults. The 89 items each contribute to five subscale scores on the BDEFS.
Each subscale represents a different aspect of executive functioning that contributes to
impairment in daily life activities. There is also a BDEFS Total Executive Functioning
Summary score (BDEFS Summary score). These subscales are (a) Self-Management to
Time, (b) Self-Organization/Problem Solving, (c) Self-Restraint, (d) Self-Motivation, (e)
and Self-Regulation of Emotion as well as a BDEFS Summary score. The latter is
calculated by summing the responses to all of the items on the BDEFS. Higher scores on
a subscale of the BDEFS reflect greater impairment of executive functioning. Scores on
the Self-Management to Time subscale range from 21 to 84. Scores on the SelfOrganization/Problem Solving subscale range from 24 to 96. Scores on the Self-Restraint
subscale range from 19 to 76. Scores on the Self-Motivation subscale range from 12 to
48. Scores on the Self-Regulation of Emotion subscale range from 13 to 52. The BDEFS
Summary score can range from 89-356. Higher scores reflect greater dysfunction in the
executive functioning domain, whereas lower scores reflect intact executive functioning.
The BDEFS Summary score is calculated by summing all items. This is
converted to a percentile rank based on a subject’s gender and age group. A subject’s
percentile score represents the portion of individuals in the normative sample they scored
higher than on the BDEFS. An ADHD-EF index score is calculated from the sum of 11
items distributed throughout the measure that represent common executive functioning
difficulties individuals with ADHD experience. The subscale scores, total executive
functioning summary score, and ADHD-EF index score all demonstrated satisfactory
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internal consistency (Cronbach’s α ranged from 0.958 to 0.842) and test-retest reliability
(r ranged from 0.62 to 0.90; Barkley, 2011b). Research validating the BDEFS measure
found it has good convergent validity with the Coding task from the WAIS-IV (R2 =
0.27; Barkley, 2011b). Research examining the BDEFS and a measure of goal-directed
selective attention in a sample of college students with ADHD found support for the
discriminant validity of the BDEFS (Dehili et al., 2017).
Wechsler Adult Intelligence Scale-Fourth Edition (WAIS-IV)
The WAIS-IV is an intelligence test battery designed to measure intellectual
functioning in specific cognitive domains and general intellectual ability. Subjects were
administered select subtests from the WAIS-IV as part of the ADHD evaluation process.
This study used the Coding task and the Digit Span task as measures of impaired
cognitive processes. The Coding task is a test of cognitive processing speed. The Digit
Span task measures auditory working memory for numbers. Extensive testing has proven
the reliability and validity of the WAIS-IV and its subtests in a variety of populations
(Wechsler, 2008).
Procedures
This was a secondary analysis of data were gathered from new clients during
intake at a university-based, adult ADHD outpatient specialty clinic in a large urban area.
The aforementioned measures were completed as part of a comprehensive ADHD
assessment. Research assistants and the administrators of the psychological assessment
recorded the data from these measures, de-identified it, and copied the data into an SPSS
data file. Human subjects research utilizing this data set was approved by a Institutional
Review Board (IRB). Subjects had already completed the evaluation and signed a consent
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form agreeing to let their private information be used in research studies and informing
them of the minimal risk to the participants. This study utilized the data of participants
who met the requirements of the inclusion and exclusion criteria collected between
January 2014 and May 2019 for the analyses.
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Chapter 4: Results
Diagnostic Group Creation
This study examined the relationship between ADHD, SCT, internalizing
symptoms, and cognitive functioning. The sample consisted of 143 participants who
presented for a comprehensive evaluation at an adult ADHD outpatient specialty clinic.
Data were analyzed across the following four diagnostic subgroups: ADHD + SCT,
ADHD + subclinical SCT, ADHD only, and SCT only; they could be distinguished from
one another based on the degree of self-reported internalizing symptoms and impaired
cognitive functioning. The study also examined which co-occurring internalizing
symptoms and aspects of cognitive functioning were most predictive of SCT.
These four groups were created by sorting the participants according to their score
on the SCT subscale of the BAARS-IV. Cutoff percentile scores for each group were
determined by following Barkley’s validation research on the BAARS-IV, which found
the SCT subscale scores at the 93rd percentile or higher reflected clinically significant
levels of SCT symptomatology (2011a). Those whose SCT scores were in the Borderline
range as outlined in the BAARS-IV manual (85th to 92nd percentile) do not meet criteria
for SCT, while still having notable levels SCT symptomatology. This range of scores
reflects subclinical levels of SCT (Barkley, 2011a).
The ADHD + SCT group consisted of participants who met or exceeded the 93rd
percentile for their reference age group on the SCT subscale (the threshold for clinically
significant levels of SCT outlined in the BAARS-IV manual) and met criteria for an
ADHD diagnosis, as determined by the CAARS and SCID-5, which was part of the
original comprehensive evaluation. Seventy-four subjects from the data set met criteria
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for ADHD + SCT and had all relevant data needed to conduct the analyses. The ADHD +
subclinical SCT group consisted of 36 subjects whose SCT subscale scores were between
the 85th and 92nd percentile for their reference age group, received an ADHD diagnosis,
and had all relevant data needed to conduct the analyses.
The ADHD-only group consisted of 26 subjects who received an ADHD
diagnosis, their SCT subscale score was below or equal to the 84th percentile for their
reference age group, and had all relevant data needed to conduct the analyses. The SCTonly group consisted of seven subjects who met or exceeded the 93rd percentile for their
reference age group on the SCT subscale, had all relevant data needed to conduct the
analyses, and either did not receive an ADHD diagnosis or received a diagnosis of Other
Specified ADHD. This diagnosis is used by the adult ADHD outpatient specialty clinic to
communicate that an individual has clinical levels of SCT symptomatology, but does not
meet full criteria for an ADHD diagnosis. Means and standard deviations for each
diagnostic group’s scores on the measures of internalizing symptoms and cognitive
functioning are presented in Table 1.
Demographic Analysis
The sample consisted of 93 males and 50 females. The mean age was 34.17, with
a standard deviation of 12.69, a median age of 31, and an age range of 18 to 72. Subjects
identified as 77.6% Caucasian, followed by 10.5% other, 3.5% African American, 3.5%
Hispanic, and 2.8% Asian. Data on ethnicity was not available for three subjects.
Subjects had a mean education level of 15.74 years, with a standard deviation of 2.21,
and range of 11 to 21.
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Table 1
Internalizing Symptoms and Cognitive Functioning Across the Diagnostic Groups
Diagnostic

BDEFS

Group
ADHD +
SCT

BDI-II PSWQ

BADDS- Coding

Digit

NEO-

Summary

Affect

Task

Span

Neuroticism

M

18.88

57.95

96.00

67.50

9.41

10.69

59.01

SD

11.08

14.17

4.93

12.58

2.86

3.03

12.58

M

14.64

50.06

90.47

59.39

9.81

10.19

56.72

SD

8.69

14.43

12.28

12.02

2.66

2.66

10.23

M

10.92

48.46

88.58

60.58

10.35

10.19

55.50

SD

7.41

16.36

8.87

10.91

3.25

1.96

11.97

M

22.71

45.57

94.57

68.43

9.43

11.57

59.71

SD

19.63

24.67

6.43

16.07

4.28

2.70

18.42

M

16.55

53.63

93.19

64.24

9.68

10.52

57.83

SD

10.91

15.76

8.67

12.79

2.95

2.75

12.21

(n = 74)
ADHD +
subclinical
SCT
(n = 36)
ADHD-only
(n = 26)
SCT-only
(n = 7)
Total sample
(N = 143)

Note: BDI-II = Beck Depression Inventory-II; PSWQ = Penn State Worry Questionnaire;
BDEFS Summary = Barkley Deficits in Executive Functioning Scale: Self Report - Total EF
Summary % score; BADDS-Affect = Brown ADD Scales-Affect, T Score; Coding Task =
WAIS-IV Digit Symbol Coding Scaled Score; Digit Span task = WAIS-IV Digit Span, Scaled
Score; NEO-Neuroticism = NEO-Personality Inventory-Neuroticism-T Score.
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Hypothesis 1 Analysis
It was hypothesized that there would be a significant difference between subjects
diagnosed with ADHD + SCT, ADHD + subclinical SCT, ADHD only, and SCT only,
with those diagnosed with ADHD + SCT having higher levels of internalizing symptoms
than the other groups. Internalizing symptoms were operationally defined as scores on the
BDI-II, Penn State Worry Questionnaire (PSWQ), the affect subscale of the Brown
Attention Deficit Disorder Scale-Adult Version (BADDS), and Neuroticism scale of the
NEO-PI-R.
A multiple analysis of variance (MANOVA) was conducted to examine whether
subjects’ scores on the BDI-II, PSWQ, BADDS-Affect, and NEO-Neuroticism differed
significantly between those who exhibited clinical levels of ADHD + SCT, ADHD +
subclinical SCT, only SCT, and only ADHD. Diagnostic category served as the
independent variable for this study.
The assumptions of the MANOVA were tested by examining the normality,
linearity, homoscedasticity, and multicollinearity of the data. To test the normality of the
data, the skew and kurtosis of the data were calculated for the relevant variables. The
skew and kurtosis of the variables used in these analyses were found to be within normal
limits. Levene’s test was used to examine the homogeneity of the variance across the
groups. The results of Levene’s test (Table 2) found the variance was unequal between
the four diagnostic groups for subjects’ scores on the BDI-II, F(3, 139) = 5.409, p =
0.002. The variance was also unequal for subjects’ scores on the PSWQ for the four
diagnostic groups, F(3, 139) = 3.345, p = 0.021.
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The variance-covariance ratio was tested using Box’s test of equality of
covariance matrices. The Box’s M value of 55.468 was found to be not significant (p =
0.02), indicating the assumptions of homogeneity covariance were met between the
diagnostic groups. Due to unequal sample size, violation of the assumptions of equal
variance, and groups differing along more than one variate, Pillai’s trace was used as the
significance statistic because it is more robust than the other statistics to violations of
model assumptions (Field, 2013; Olson, 1974).

Table 2
Levene’s Test of Equality of Error Variances in Measures of Internalizing Symptoms

F

df1

df2

p

NEO-Personality Inventory-Neuroticism

2.382

3

139

.072

Beck Depression Inventory-II

5.409

3

139

.002

Penn State Worry Questionnaire

3.345

3

139

.021

Brown ADD Scales-Affect, T Score

1.512

3

139

.214

a

Design: Intercept + Diagnostic group

Scores from the BADDS-Affect, BDI-II, PSWQ, and Neuroticism scale of the
NEO-PI-R were tested for linearity and multicollinearity. As required for MANOVA,
these dependent variables demonstrated significant correlations with one another, ranging
from 0.244 to 0.517 (p < 0.01). These correlations are provided in Table 3. Bonferroni
corrections were used to account for the potential of increased Type I experiment-wise
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error rate caused by conducting multiple statistical tests in this study. To correct for the
experiment-wise error rate of three comparisons the critical p value was set at 0.01, with
a desired power level of 0.80. Using Pillai’s trace, there was a significant effect of
diagnostic group on subjects’ scores on the measures of internalizing symptoms, V =
0.198, F(12, 414) = 2.439, p = .004. The observed power for this MANOVA was .897.
Results from the multivariate tests are provided in Table 4.

Table 3
Summary of Pearson Correlations Between Measures of Internalizing Symptoms
NEO- Neuroticism BDI-II

PSWQ

BADDS-Affect

-

.244**

.409***

.328***

Beck Depression Inventory-II

.244**

-

.255**

. 517***

Penn State Worry Questionnaire

.409***

.255**

-

.447***

Brown ADD Scales-Affect, T Score

.328***

.517***

.447***

-

NEO-Personality InventoryNeuroticism, T Score

Note: BDI-II = Beck Depression Inventory-II; PSWQ = Penn State Worry Questionnaire;
BADDS-Affect = Brown ADD Scales-Affect, T Score; NEO-Neuroticism = NEOPersonality Inventory-Neuroticism-T Score.
**

p < .01 one-tailed, ***p < .001 one-tailed
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Table 4
Multivariate Tests for Differences in Internalizing Symptoms Between Groupsa
Partial Eta Noncent. Observed
Intercept

Value

F

Hyp. df Error df

p

Squared

Parameter

Powerd

Pillai’s Trace

.953 691.63b

4

13

.000

.953

2766.53

1.00

Wilks’ Lambda

.047 691.63b

4

136

.000

.953

2766.53

1.00

Hotelling’s Trace 20.342 691.63b

4

136

.000

.953

2766.53

1.00

20.342 691.63b

4

136

.000

.953

2766.53

1.00

Roy’s Largest
Root
Diagnostic group
Pillai’s Trace

.198

2.44

12

414

.004

.066

29.26

.897

Wilks’ Lambda

.812

2.46

12

360.11 .004

.067

25.90

.943

Hotelling’s Trace

.220

2.46

12

404

.004

.068

29.57

.971

Roy’s Largest

.146

5.026c

4

138

.001

.127

20.11

.959

Root
Note. Hyp. df = Hypothesis degrees of freedom
a

Design: Intercept + Diagnostic group

b

Exact statistic

c

The statistic is an upper bound on F that yields a lower bound on the significance level.

d

Computed using α = .01
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A univariate ANOVA revealed subjects’ NEO-Neuroticism scores did not differ
significantly between the diagnostic groups, F(3, 139) = 0.698, p = 0.555. Separate
univariate ANOVAs also revealed significant effects of diagnostic group on the BDI-II,
F(3, 139) = 4.914, p = 0.003; PSWQ, F(3, 139) = 4.286, p = 0.006; and BADDS-Affect,
F(3, 139) = 4.617, p = 0.004. The observed power for these univariate ANOVAs ranged
from 0.068 to 0.751. The results of these univariate ANOVAs are provided in Table 5.

Table 5
Univariate Analysis of Variance Tests Comparing Between-Groups Effects for
Internalizing Symptoms
Observed
Dependent Variable
Corrected

model

Type III SS

MS

F

313.835a

3

104.61

.698

.555

.068

BDI-II

1621.871b

3

540.62

4.914**

.003

.751

PSWQ

2987.508c

3

995.84

4.286**

.006

.670

BADDS-

2105.318d

3

701.77

4.617**

.004

.715

NEO-

p

Power

df

Neuroticism

Affect
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Dependent
Variable
Intercept

Observed
Type III SS

MS

239602.529

1

239602.53

1598.260***

.000

1.000

BDI-II

20258.501

1

20258.50

184.126***

.000

1.000

PSWQ

183360.727

1

183360.73

789.177***

.000

1.000

BADDS-

294155.445

1

294155.45

1935.314***

.000

1.000

313.835

3

104.61

.698

.555

.068

BDI-II

1621.871

3

540.62

4.914***

.003

.751

PSWQ

2987.508

3

995.84

4.286***

.006

.670

BADDS-

2105.318

3

701.77

4.617***

.004

.715

20838.137

139

149.92

BDI-II

15293.486

139

110.03

PSWQ

32295.848

139

232.34

BADDS-

21127.116

139

151.99

NEO-

F

p

Power

df

Neuroticism

Affect
Diagnostic
group

NEONeuroticism

Affect
Error

NEONeuroticism

Affect
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Dependent
Variable
Total

Observed
Type III SS

df

499424

143

BDI-II

56095

143

PSWQ

446567

143

BADDS-

613449

143

NEO-

MS

F

p

Power

Neuroticism

Affect
Corrected
total

NEO-

21151.972

142

BDI-II

16915.357

142

PSWQ

35283.357

142

BADDS-

23232.434

142

Neuroticism

Affect
Note. BDI-II = Beck Depression Inventory-II; PSWQ = Penn State Worry Questionnaire;
BADDS-Affect = Brown ADD Scales-Affect, T Score; NEO-Neuroticism = NEO-Personality
Inventory-Neuroticism-T Score.
a 2

R = .015, bR2 = .096, cR2 = .085, dR2= .091

*p < .05, **p < .01, ***p < .001

The results of these post hoc ANOVAs should be interpreted with caution
regarding the BDI-II and PSWQ, due to significant findings from Levene’s test. Field
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admits that he includes the Levene’s test in his book out of expectation from others only.
Field points out that Levene’s test can be statistically significant in larger samples, in
which there are small effects that have less practical significance. Field reports that many
statisticians have discontinued using the test, specifically for two reasons, one of which is
relevant in the present context. Of importance, Levene’s test is less practical with larger
sample sizes and when groups are not equal. This is precisely the case in the present
instance. Although there are many ways of adjusting the data to resolve differences in
variances, there is controversy about doing so as well. Field (2018) recommends using
robust statistical analysis as the best alternative.
In line with Field (2018), because there were significant differences in variances
between the diagnostic groups for the BDI-II and PSWQ, robust tests of equality of
means were performed in each instance. Although the original post hoc ANOVAs
between groups were significant for the BDI-II (p =.003) and PSWQ (p = .006), the
results from performing a Brown-Forsythe were not significant. For the BDI-II the
Brown-Forsythe statistic (3, 12.295) = 3.077, p = .067. For the PSWQ the BrownForsythe statistic (3, 18.841) = 2.844, p = .065. By using this more robust statistic, in
each instance the results went from being statistically significant to approaching
significance only. For these reasons post hoc testing with the Tukey was not performed
on the BDI-II and PSWQ.
Post hoc comparisons using the Tukey HSD indicated that the mean score for the
ADHD + SCT group on the BADDS-Affect scale was significantly higher than the mean
BADDS-AFFECT score of those in the ADHD + subclinical SCT group (p < .01). The
results of these post hoc analyses are provided in Table 6. It is important to note that the
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group sizes used in these analyses are unequal. The harmonic mean of the group sizes is
used, Type I error levels may be inaccurate.
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Table 6
Post Hoc Comparisons of Affect Regulation Using Tukey’s HSD
95% CI

Mean
Dependent
Variable
Brown ADD

(I) Diagnostic

(J) Diagnostic

Difference

group

group

(I-J)

SE

8.11**

ADHD-only
SCT-only

ADHD + SCT

Scales-Affect,

Lower

Upper

p

Bound

Bound

2.505

.008

1.60

14.63

6.92

2.811

.070

-.39

14.23

-.93

4.875

.998

-13.61

11.75

-8.11**

2.505

.008

-14.63

-1.60

ADHD-only

-1.19

3.173

.982

-9.44

7.06

SCT-only

-9.04

5.093

.290

-22.28

4.20

ADHD + SCT

-6.92

2.811

.070

-14.23

.39

ADHD +

1.19

3.173

.982

-7.06

9.44

-7.85

5.250

.443

-21.50

5.80

ADHD + SCT

.93

4.875

.998

-11.75

13.61

ADHD +

9.04

5.093

.290

-4.20

22.28

7.85

5.250

.443

-5.80

21.50

ADHD +
subclinical SCT

T Score

ADHD +
subclinical SCT

ADHD-only

ADHD + SCT

subclinical SCT
SCT-only
SCT-only

subclinical SCT
ADHD-only
Note. The error term is MS (Error) = 151.994.
**

p < .01
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Hypothesis 2 Analysis
It was hypothesized that there would be a significant difference between subjects
diagnosed with ADHD + SCT, ADHD + subclinical SCT, ADHD-only, and SCT only,
with those diagnosed with ADHD + SCT exhibiting significantly more impaired
cognitive functioning than all other groups. Impaired cognitive functioning was
operationally defined as standardized scores from the Coding task and Digit Span task, as
well as the BDEFS Summary score, A MANOVA was conducted to determine if the
scores on the measures of cognitive functioning significantly differed between subjects
who exhibited ADHD + SCT, ADHD + subclinical SCT, SCT only, or ADHD-only.
To correct for the experiment-wise error rate of three comparisons, the critical p
value was set at 0.01. An a priori power analysis determined that a sample size of 120
would be required to achieve the minimal power level of 0.8 with p = 0.01, four groups,
and three dependent variables. Of the total sample of 143 subjects, there were 74 in the
ADHD + SCT group, 36 in the ADHD + subclinical SCT group, 24 in the ADHD-only
group, and seven in the SCT-only group.
Tests of normality revealed a negative skew (-3.138) and a leptokurtic distribution
(12.022) for subjects’ BDEFS Summary score. Skew and kurtosis were within normal
limits for subjects’ scores on the Coding task and Digit Span task. Although the
distribution of subjects’ BDEFS Summary scores violates the assumptions of normalcy,
this distribution makes sense because this is a clinical sample of individuals with ADHD,
SCT, or both. These diagnoses are associated with difficulties in executive functioning.
The variance-covariance ratio was tested using Box’s test of equality of covariance
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matrices. Box’s M was calculated to be 13.316 and was found to be not significant
(p =.187), indicating the assumptions of equal variance were met.
Scores from the Coding task, Digit Span task, and BDEFS Summary were tested
for linearity and multicollinearity. As shown in Table 7, none of these variables were
correlated at the critical significance level (p > .01). As per the MANOVA, there were no
significant effects of diagnostic group on subjects’ scores on the measures of cognitive
functioning. Specifically, using Pillai’s trace there was not a significant effect of the
diagnostic group on measures of cognitive functioning, V = .035, F(6, 278) = .828, p =
.55. Using Wilks’ lambda, there was not a significant effect of the diagnostic group on
measures of cognitive functioning, Λ = .965, F(6, 276) = .827, p = .55. Using Hotelling’s
trace statistic, there was not a significant effect of the diagnostic group on measures of
cognitive functioning, T = .036, F(6, 276), = .824, p = .55. Using Roy’s largest root test,
there was not a significant effect of the diagnostic group on measures of cognitive
functioning, Θ = .033 F(3, 139) = 1.511, p = .214. The measures of cognitive functioning
examined did not significantly differ between subjects who exhibited varied levels of
ADHD and SCT symptomatology in this analysis. Therefore, univariate tests of between
subjects’ effects were not interpretable.
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Table 7
Correlations Between Measures of Cognitive Functioning
BDEFS

Barkley Deficits in Executive Functioning

Summary

Coding task

Digit Span task

-

-.081

.146*

-.081

-

.184*

.146*

.184*

-

Scale: Self Report - Total EF Summary
WAIS-IV Digit Symbol Coding, Scaled
Score
WAIS-IV Digit Span, Scaled Score

Note. BDEFS Summary = Barkley Deficits in Executive Functioning Scale: Self Report Total EF Summary. Coding task = WAIS-IV Digit Symbol Coding, Scaled Score. Digit
Span task = WAIS-IV Digit Span, Scaled Score.
*

p < .05 1-tailed
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Table 8
Multivariate Tests for Differences in Cognitive Functioning Between Groupsa
Partial Eta Noncent. Observed
Intercept

Value

F

Hyp. df Error df

p

Squared

Parameter

Powerd

Pillai’s Trace

.918 769.097b

2

138

.00

.918

1538.194

1.000

Wilks’ Lambda

.082 769.097b

2

138

.00

.918

1538.194

1.000

Hotelling’s Trace 11.146 769.097b

2

138

.00

.918

1538.194

1.000

Roy’s Largest

2

138

.00

.918

1538.194

1.000

11.146 769.097b

Root
Diagnostic group
Pillai’s Trace

.035

.828

6

278

.55

.018

4.970

.327

Wilks’ Lambda

.965

.827b

6

276

.55

.018

4.963

.326

Hotelling’s Trace

.036

.826

6

274

.55

.018

4.956

.326

Roy’s Largest

.033

1.511c

3

139

.21

.032

4.534

.392

Root
Note. Hyp. df = Hypothesis degrees of freedom
a

Design: Intercept + Diagnostic group

b

Exact statistic

c

The statistic is an upper bound on F that yields a lower bound on the significance level.

d

Computed using α = .05
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Hypothesis 3 Analysis
It was hypothesized that anxiety and deficits in executive functioning would
predict SCT after accounting for ADHD symptomatology. SCT was operationally
defined as subjects’ percentile rank on the BAARS-IV SCT subscale (SCT Percentile
Rank). Anxiety was operationalized as subjects’ scores on the PSWQ. Executive
functioning was operationalized as subjects’ BDEFS Summary score. ADHD
symptomatology was operationally defined as subjects’ scores on the DSM-IV Inattentive
symptoms and DSM-IV Hyperactive/Impulsive symptoms scales of the CAARS.
A regression analysis was conducted to examine the associations between
internalizing symptoms (operationalized as scores on the BDI-II, PSWQ, BADDS-Affect,
and NEO-Neuroticism) and cognitive functioning (operationalized as BDEFS Summary,
Digit Span task, and Coding Task) on the one hand, and SCT symptomatology, on the
other hand. The normality, homoscedasticity, linearity, and multicollinearity of the data
were examined to test the assumptions of this regression analysis. To test the normality of
the data, a frequencies distribution calculated the skew and kurtosis of the data. Subjects’
SCT Percentile Ranks were found to be negatively skewed (-2.317) and leptokurtic
(6.939). Subjects’ BDEFS Summary scores were negatively skewed
(-3.128) and leptokurtic (12.022). Bonferroni corrections were used to account for the
increased Type I experiment-wise error rate caused by conducting multiple statistical
tests on the same data set. To correct for the experiment-wise error rate of three
comparisons, the critical p value was set at 0.01.
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Table 9
Summary of Pearson Correlations Between Measures of SCT, Internalizing Symptoms,
and Cognitive Functioning
Measure
1. SCT Percentile

1

2

3

4

5

6

-

.11

.05

.33**

.23**

.11

-

.04

.00

.01

.05

.05

.04

-

.02

.04

.33**

.00

.02

-

.23**

.01

.04

.28**

.05

-.01

7

8

9

.07

.46**

.01

-.09

.07

-.01

-.16

-.07

.15*

.02

.52**

-.08

-.13

.24**

.02

-

.45**

-.12

.04

.42**

.52**

.45**

-

-.03

-.06

.35**

.28** -.14*

Rank
2. CAARS
Inattentive T
Score
3. CAARS
Hyperactive/Impul
sive T Score
4. Beck Depression
Inventory-II
5. Penn State Worry
Questionnaire
6. Brown ADD
Scales-Affect, T
Score

ADULTS WITH ADHD AND SLUGGISH COGNITIVE TEMPO

Measure
7. WAIS-IV Coding
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1

2

3

4

5

6

7

8

9

-.14*

.01

-.16*

-.08

-.12

-.03

-

.18*

-.08

.07

-

-.07

-.13

.04

-.06

.18*

-

.15*

.15*

.24**

.42**

.35**

-.08

.15*

-

Task, Scaled
Score
8. WAIS-IV Digit
Span, Scaled

.09

Score
9. Barkley Deficits in .46**

.07

Executive
Functioning Scale:
Self Report - Total
EF Summary
Note. 1 = Barkley Adult ADHD Rating Scale: Self report Current Symptoms - sluggish
cognitive tempo, Percentile Rank; 2 = Conners Adult ADHD Rating Scales-Inattentive
Symptoms, T Score; 3 = Conners Adult ADHD Rating Scales-Hyperactive-Impulsive
Symptoms, T Score; 4 = Beck Depression Inventory-II; 5 = Penn State Worry
Questionnaire; 6 = Brown ADD Scales-Affect, T Score; 7 = WAIS-IV Digit Symbol
Coding, Scaled Score; 8 = WAIS-IV Digit Span Task, Scaled Score.
*

p < .05 one-tailed, **p < .01 one-tailed

The association between scores on the measures of cognitive processing and
internalizing symptoms were examined using Pearson product-moment correlations to
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determine which variables were to be retained for regression analysis. There was no
significant relationship found between SCT Percentile Rank and scores on the CAARS
inattentive subscale, r = .111, p = .093; or between SCT Percentile Rank and scores on
the CAARS hyperactive/impulsive subscale, r = .049. p =.280. SCT Percentile Rank also
did not evince a significant relationship with performance on the Digit Span task, r =
.066, p = .217. Subjects’ scores on the BDI-II, PSWQ, BADDS-Affect, Coding task, and
BDEFS Summary all demonstrated significant Pearson product-moment correlations with
SCT Percentile Rank (See Table 9 for details of the correlational matrix). There was a
significant relationship between BDI-II scores and SCT Percentile Rank, r = .329, p <
.001. There was also a significant relationship between PSWQ scores and SCT Percentile
Rank, r = .225, p = .003. Scores from the BADDS-Affect scale were significantly related
to SCT Percentile Rank, r = .277, p = .000. In addition, there was a significant
relationship between Coding Task scores and SCT Percentile Rank, r = -.138, p = .050.
Finally, there was a significant relationship between BDEFS Summary scores and SCT
Percentile Rank, r = .463, p < .001.
Original statistical regression plan for hypothesis 3. The original statistical
regression plan, which was not used in this study, was to enter the CAARS Inattentive
and CAARS Hyperactive/Impulsive symptom scales into regression model 1 as the only
predictor variables for SCT Percentile Rank. This would have been intended to examine
the relationship between ADHD symptomatology and SCT and to account for the strong
relationship between ADHD and SCT seen in previous research.
Regression model 2 would have retained the CAARS scores and added relevant
scores from the measures of internalizing symptoms (BDI-II, PSWQ, and BADDS-
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Affect) and cognitive functioning (BDEFS Summary score and the Coding task) as
predictor variables for SCT Percentile Rank. Howeverbecause neither of the CAARS
scores was correlated with the dependent variable in these analyses, there was no need to
ensure they were entered hierarchically as the first predictors into the model. Therefore,
all five remaining predictors were entered into the regression model using the forced
entry method.
Statistical regression testing hypothesis 3. The regression model used in this
study, including the BDI-II, PSWQ, BADDS-Affect, BDEFS Summary, and Coding
Task as predictors, was found to predict a significant portion of the variance in SCT
Percentile Rank scores (R = .523; R2 = .274, p < .001). The Durbin-Watson test found the
autocorrelation of the model’s residuals was within an acceptable range (1.042). The
adjusted coefficient of determination indicates shrinkage of only 2.6% (Adjusted R2 =
.248) if this model was generalized to the population of adults with either ADHD or SCT.
Details of the model summary can be found in Table 10.
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Table 10
Regression Model Summary Utilizing Measures of Internalizing Symptoms and Cognitive
Functioning to Predict SCT Percentile Ranks
Adjusted

SE of the

R2

R

R2

R2

Estimate

Change

.523a

.274

.248

9.67217

.274

Sig. F Durbin-

F

Change df1 df2 Change Watson
10.343

5

137

.000

1.042

Predictors: (Constant), Barkley Deficits in Executive Functioning Scale: Self Report –

a

Total EF Summary, WAIS-IV Digit Symbol Coding Scaled Score, Beck Depression
Inventory-II, Penn State Worry Questionnaire, Brown ADD Scales-Affect T Score

As shown in Table 11, the overall regression analysis was significant, indicating
the regression model predicted SCT Percentile Ranks significantly better than chance,
F(5,137) = 10.34, p <.001. Two of the predictor variables were found to significantly
contribute to the regression model. Scores on the BDI-II significantly predicted SCT
Percentile Rank, β = .215, t(137) = 2.514. p = .013. Additionally, BDEFS Summary
scores significantly predicted SCT percentile, β = .403, t(137) = 4.921, p < .001. Other
predictor variables were not significantly associated with SCT Percentile Rank in the
regression model. Tolerance and Variance Inflation Factor for all predictor variables were
normal, indicating no significant multicollinearity. Detailed statistics for each predictor
variable can be found in Table 12.
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Table 11
Overall Regression Analysis With Predictor Variables to Subjects’ SCT Percentile
Ranksa
Model 1

SS

df

MS

F

p

4837.768

5

967.554

10.343***

.000b

Residual

12816.469

137

93.551

Total

17654.237

142

Regression

a

Dependent Variable: Barkley Adult ADHD Rating Scale: Self report Current Symptoms

- sluggish cognitive tempo, Percentile based on age and raw score.
b

Predictors: (Constant), Barkley Deficits in Executive Functioning Scale: Self Report -

Total EF Summary, WAIS-IV Digit Symbol Coding Scaled Score, Beck Depression
Inventory-II, Penn State Worry Questionnaire, Brown ADD Scales-Affect T Score.
***

p < .001
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Table 12
Coefficients of Predictor Variables to Subjects’ SCT Percentile Ranksa

Model 1
(Constant)
Beck Depression

Unstandardized

Standardized

Collinearity

Coefficients

Coefficients

Statistics

B

SE

40.845

9.603

.220

.087

-.016

β

Tolerance

VIF

.013

.724

1.380

-.262

.794

.716

1.397

.033

.355

.723

.609

1.642

.278

-.090

-1.219

.225

.977

1.023

.105

.403***

4.921

.000

.790

1.266

t

p

4.253

.000

.215*

2.514

.061

-.023

.029

.081

-.339

.518

Inventory II
Penn State Worry
Questionnaire
Brown ADD Scales-Affect, T
Score
WAIS-IV Digit Symbol
Coding, Scaled Score
Barkley Deficits in Executive
Functioning Scale: Self
Report - Total EF Summary

Note. VIF = Variance Inflation Factor
a

Dependent Variable is Barkley Adult ADHD Rating Scale: Self report Current

Symptoms - sluggish cognitive tempo, Percentile based on age and raw score
*

p < .05, ***p < .001
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Exploratory Analyses
Two exploratory analyses were conducted and are explored below.
Diagnostic group differences in executive functioning
A one-way ANOVA was conducted to explore whether subjects from the
diagnostic groups, differed significantly in executive functioning, operationalized as
BDEFS Summary scores. To correct for the experiment-wise error rate, the critical p
value was set at .01. As previously mentioned, tests of normality revealed a negative
skew (-3.138) and a leptokurtic distribution (12.022) for BDEFS Summary scores. This
violates the assumption of normality of the data for the ANOVA.
Results of the one-way ANOVA found there was a significant difference between
the four diagnostic groups on BDEFS Summary scores, F(3,139) = 7.08, p <.001. A
Bonferroni corrected post hoc revealed subjects with ADHD + SCT had significantly
higher mean BDEFS Summary scores than the ADHD + subclinical SCT subjects, p =
.007, d = 5.53. Significant differences were also noted between ADHD + SCT subjects’
higher mean BDEFS Summary scores compared to the ADHD-only subjects, p = .001, d
= 7.42. No significant differences were found between the seven subjects with SCT only
and the other diagnostic groups and no significant differences were found between the
ADHD + subclinical SCT groups’ mean BDEFS Summary scores and the mean scores of
the SCT-only or ADHD-only groups. A post hoc Tukey HSD test found the same pattern
of significant findings. Results of the post hoc tests are provided in Table 13 and Table
14. This exploratory analysis implies that executive functioning measures may be the best
indicators of the kinds of cognitive functioning issues that differentiate ADHD and SCT
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symptomatology, as opposed to tests like the Coding and Digit Span tasks from the
WAIS-IV in adults with ADHD + SCT.

Table 13
Results of One-Way Analysis of Variance Examining Diagnostic Group Influence on
Subjects’ BDEFS Scores
SS

df

MS

F

p

Between Groups

1416.869

3

472.290

7.084***

.000

Within Groups

9267.033

139

66.669

Total

10683.902

142

***

p < .001
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Table 14
Post Hoc Tukey’s HSD and Bonferroni Tests Examining Difference Between Diagnostic
Groups’ Mean Scores on the BDEFS Summary Score
95% CI
Diagnostic

Diagnostic

Mean

Lower

Upper

Group (I)

Group (J)

Difference (I-J)

SE

p

Bound

Bound

5.528**

1.659

.006

1.21

9.84

7.423**

1.861

.001

2.58

12.26

1.429

3.229

.971

-6.97

9.82

-5.528*

1.659

.006

-9.84

-1.21

subclinical ADHD-only

1.895

2.101

.804

-3.57

7.36

SCT

SCT-only

-4.099

3.373

.618 -12.87

4.67

ADHD-

ADHD + SCT

-7.423*

1.861

.001 -12.26

-2.58

only

ADHD +

-1.895

2.101

.804

-7.36

3.57

-5.995

3.477

.315 -15.04

3.05

-1.429

3.229

.971

-9.82

6.97

4.099

3.373

.618

-4.67

12.87

5.995

3.477

.315

-3.05

15.04

Tukey’s HSD ADHD +
SCT

ADHD +
subclinical SCT
ADHD-only
SCT-only

ADHD +

ADHD + SCT

subclinical SCT
SCT-only
SCT-only ADHD + SCT
ADHD +
subclinical SCT
ADHD-only
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95% CI

Bonferroni

Diagnostic

Diagnostic

Mean

Group (I)

Group (J)

Difference (I-J)

SE

5.528**

ADHD +

ADHD +

SCT

subclinical SCT
ADHD-only
SCT-only

ADHD +

ADHD + SCT

subclinical ADHD-only

Lower

Upper

p

Bound

Bound

1.659

.007

1.09

9.97

7.423**

1.861

.001

2.44

12.41

1.429

3.229

1.00

-7.21

10.07

-5.528**

1.659

.007

-9.97

-1.09

1.895

2.101

1.00

-3.73

7.52

-4.099

3.373

1.00 -13.13

4.93

-7.423**

1.861

.001 -12.41

-2.44

-1.895

2.101

1.00

-7.52

3.73

-5.995

3.477

.521 -15.30

3.31

-1.429

3.229

1.00 -10.07

7.21

4.099

3.373

1.00

-4.93

13.13

5.995

3.477

.521

-3.31

15.30

SCT
SCT-only
ADHD-

ADHD + SCT

only

ADHD +
subclinical SCT
SCT-only

SCT-only ADHD + SCT
ADHD +
subclinical SCT
ADHD-only
*

p < .05 **p < .01.
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The impact of SCT in adults with ADHD on internalizing disorders and
cognitive functioning. An additional exploratory MANOVA was conducted to examine
whether the degree of internalizing symptoms and cognitive functioning varied in adults
with ADHD who have differing levels of SCT. Diagnostic groups served as the
independent variable in this analysis. The measures of internalizing symptoms and
cognitive functioning that were found to significantly differ between diagnostic groups
across the previous analyses in this study served as the dependent variables. The seven
subjects with SCT only were not included in these analyses because they did not exhibit
clinically significant levels of ADHD.
Previous analyses found subjects’ BDEFS Summary scores were positively
skewed and leptokurtic, with a skew of 3.128 (SE = 0.203) and kurtosis of 12.022 (SE =
0.403). Box’s test found that the assumptions of homogeneity of covariance were not met
between the diagnostic groups. The value of Box’s M was calculated as 95.388 and was
found to be significant (p < .001).
Levene’s test indicated that the homogeneity of variance across groups was
unequal. As indicated in Table 15, the variance in subjects scores was unequal between
the three diagnostic groups on the BDI-II, F(2, 133) = 6.295, p = 0.002; Digit Span task,
F(2, 133) = 5.066, p = .008; and BDEFS Summary scores, F(2, 133) = 6.283, p = 0.002.
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Levene’s Test of Equality of Error Variances for Measures of Internalizing Symptoms
and Cognitive Functioning

NEO-Personality

F

df1

df2

p

.983

2

133

.377

6.295**

2

133

.002

1.387

2

133

.253

.901

2

133

.409

5.066**

2

133

.008

6.283**

2

133

.002

InventoryNeuroticism-T Score
Beck Depression
Inventory-II
Penn State Worry
Questionnaire
Brown ADD ScalesAffect, T Score
WAIS-IV Digit Span,
Scaled Score
Barkley Deficits in
Executive Functioning
Scale: Self Report Total EF Summary (15), % score
Note. Design = Intercept + Diagnostic Group
** p < .01
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Due to unequal sample sizes, groups differing along more than one variate,
violations of normalcy of the data, and the assumptions of equal covariance; Pillai’s trace
was used as the significance statistic in the MANOVA because it is more robust than the
other statistics and more appropriate for violations of model assumptions (Olson, 1974;
Field, 2013). Pillai’s trace indicated a significant overall effect of diagnostic group on
measures of the following internalizing symptoms and cognitive processing, BDI-II,
PSWQ, BADDS-Affect, and BDEFS Summary, V = 0.225, F(12. 258) = 2.720, p =
0.002. The observed power for this analysis was 0.982. Details of the MANOVA are
presented in Table 16.
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Table 16
Multivariate Tests for Differences in Internalizing Symptoms and Cognitive Functioning
Between Adults with ADHD and Varying Levels of SCTa

Intercept

Value

F

Partial Eta

Noncent.

Observed

Hyp. df

Error df

p

Squared

Parameter

Powerd

Pillai’s Trace

.992 2672.558b

6

128

.000

.992

16035.346

1.000

Wilks’ Lambda

.008 2672.558b

6

128

.000

.992

16035.346

1.000

Hotelling’s Trace

125.276 2672.558b

6

128

.000

.992

16035.346

1.000

Roy’s Largest

125.276 2672.558b

6

128

.000

.992

16035.346

1.000

Root
Diagnostic group
Pillai’s Trace

.225

2.720

12

258

.002

.112

32.643

.982

Wilks’ Lambda

.781

2.810b

12

256

.001

.116

33.715

.986

Hotelling’s Trace

.274

2.898

12

254

.001

.120

34.772

.988

Roy’s Largest

.246

5.278c

6

129

.000

.197

31.670

.994

Root

Note. Hyp. df = Hypothesis degrees of freedom
a

Design: Intercept + Diagnostic group

b

Exact statistic

c

The statistic is an upper bound on F that yields a lower bound on the significance level.

d

Computed using α = .05
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As determined by univariate ANOVA, diagnostic group had a significant effect
on BDI-II, F(2, 133) = 6.876, p = 0.001; PSWQ, F(2,133) = 5.286, p = 0.004; BADDSAffect scale, F(2, 133) = 6.714, p = 0.002; and BDEFS Summary score, F(2, 133) =
10.343, p < 0.001. However, the following were not significant: the effect of diagnostic
group on NEO-Neuroticism, F(2, 133) = 1.018, p = 0.364, and the Digit Span task, F(2,
133) = 0.543, p = 0.582. Results from the univariate ANOVAs are provided in Table 17.
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Table 17
Discriminant Analyses of Variance Examining Between-Subjects Effects of Diagnostic
Group on Dependent Variables
Dependent Variable
NEO-Personality

Type III SS

df

MS

F

p

Observed Power

287.762

2

143.881

1.018

.364

.225

1342.413

2

671.207

6.876**

.001

.917

2509.601

2

1254.801

5.826**

.004

.865

1976.481

2

988.240

6.714**

.002

.911

8.287

2

4.144

.543

.582

.138

1402.799

2

701.400

10.343***

.000

.986

InventoryNeuroticism-T
Score
Beck Depression
Inventory-II
Penn State Worry
Questionnaire
Brown ADD ScalesAffect, T Score
WAIS-IV Digit Span,
Scaled Score
Barkley Deficits in
Executive
Functioning Scale:
Self Report - Total
EF Summary
**

p < .01 ***p < .001
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Levene’s test indicated the variance was unequal between the three diagnostic
groups on the BDI-II, Digit Span task, and BDEFS Summary scores. Since there were
significant differences in variances between the diagnostic groups for the BDI-II, Digit
Span task, and BDEFS summary scores, robust tests of equality of means were performed
in each instance. Brown-Forsythe’s test indicated that the homogeneity of variance across
groups was unequal between the three diagnostic groups on the BDI-II (2, 115.844) =
8.611, p < .001 and BDEFS Summary score (2, 66.89) = 7.558, p = .001. The assumption
of homogeneity of variance was met between the groups on the Digit Span task (2,
111.652) = .663, p = .517.
The pattern of the results was the same for the original post hoc discriminant
ANOVAs and the ANOVAs utilizing the Brown-Forsythe statistic. As determined by
univariate ANOVA using the Brown-Forsythe as the F statistic, diagnostic group had a
significant effect on BDI-II, F(2, 133) = 6.876, p = 0.001; and BDEFS Summary score,
F(2, 133) = 10.343, p < 0.001. The effect of diagnostic group on the Digit Span task was
not significant, F(2, 133) = 0.543, p = 0.582.
Due to unequal homogeneity of variance, the Games Howell test was used for
post hoc comparisons of group means. The test compares the difference between each
pair of means with appropriate adjustment for the multiple testing. Because the Games
Howell post-hoc test does not assume homogeneity of variances or equal sample sizes, it
is a more robust statistic when the assumption of homogeneity of variances is violated
(Ruxton & Beauchamp, 2008).
Post-hoc comparisons using the Games Howell statistic indicated that the mean
BDI-II score of those in the ADHD + SCT group was significantly higher than those in
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the ADHD-only group (p = 0.002). The ADHD + SCT group’s mean PSWQ score was
significantly higher than both the ADHD + subclinical SCT group (p = 0.023) and the
ADHD-only group (p = 0.032). The ADHD + SCT group exhibited a significantly higher
mean score on the BADDS-Affect scale than the ADHD+ subclinical SCT (p = 0.005)
and ADHD-only group (p = 0.027). The ADHD + SCT group had a significantly higher
mean BDEFS Summary score than the ADHD + subclinical group (p = 0.003) and the
ADHD-only group (p < 0.001). The three groups investigated in this analysis did not
have significant differences between their mean scores on NEO-Neuroticism or the Digit
Span task. Detailed results of these post hoc tests are provided in the appendix. As with
previous analyses, the unequal group sizes may impact the accuracy of Type 1 error
levels in these analyses.
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Chapter 5: Discussion
The results of the current study indicate that there are significant differences
between those diagnosed with ADHD + SCT, ADHD + subclinical SCT, and ADHD
only on many of the examined measures of internalizing symptoms and cognitive
functioning. Subjects’ scores on measures of depression, worry, affect regulation, and
executive dysfunction were found to be higher amongst the subjects diagnosed with
ADHD + SCT, than those with ADHD only, or those with ADHD and subthreshold
levels of SCT, in many analyses. The handful of subjects in the SCT-only group did not
significantly differ from other groups on these measures. Measures of cognitive
processing speed, auditory working memory, and neuroticism did not differ between
groups.
The results of the analyses partially supported the first hypothesis that there would
be significant differences between the four diagnostic groups on measures of
internalizing symptoms. Similar to previous studies examining internalizing symptoms in
individuals with varying levels of ADHD and SCT symptomatology, the ADHD + SCT
group exhibited significantly higher mean scores on a self-report measure of affect
regulation than the ADHD + subclinical SCT group. Notably, these differences were not
evident in all of the diagnostic groups, in this or previous studies (Carlson & Mann, 2002;
Kamradt et al., 2018). On the other hand, the diagnostic groups did not differ on
measures of depression, anxiety, or neuroticism.
Findings from this study did not support the second hypothesis, which posited
diagnostic groups would significantly differ on measures of cognitive functioning, which
was operationalized as measures of executive functioning, cognitive processing speed,
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and auditory working memory. None of these variables were found to significantly differ
between the diagnostic groups. Previous research produced mixed results in terms of
significance and effect size when investigating the relationship between SCT and
measures of executive functioning (Barkley, 2012; Bauermeister et al., 2012; Jarrett et
al., 2017; Leikauf and Solanto, 2017), as well as SCT and measures of
neuropsychological functioning (Jacobsen et al., 2018; Bauermeister et al., 2012). This
pattern of inconsistent findings in the literature and this study may be attributable to
diffuse deficits in cognitive functioning for those with ADHD and SCT, rather than
exhibiting discrete and easily identifiable areas of impairment (Hervey et al., 2014;
Mapou, 2019). This pattern of results in our sample may have been related to a relatively
higher level of functioning in this sample, as compared to the general adult ADHD
population (more on this below).
This study also found symptoms of impaired executive functioning and
depression significantly predicted SCT symptomatology in adults who exhibit clinical
levels of ADHD or SCT symptoms. This was partially consistent with the third
hypothesis, which further predicted anxiety and executive functioning would be
associated with SCT, after accounting for ADHD symptomatology. These findings are
consistent with previous lines of research that have shown SCT symptomatology
significantly contributes to the variance in internalizing symptomatology, above and
beyond the contributions of ADHD symptoms (Becker, Langberg, et al., 2014).
Depression may be a better predictor of SCT symptomatology than anxiety, not just due
to similarities in their symptom presentations, but from common underlying symptoms,
which overlap with feeling tired and lethargic, being in a fog, being underactive or slow
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moving, and feeling apathetic or unmotivated in SCT (Becker, Marshall, & McBurnett,
2014).
Interestingly, ADHD symptomatology was not associated with SCT
symptomatology in this sample, which is directly contrary to the well-established
relationship between inattentive symptoms of ADHD and SCT symptomatology
(Barkley, 2011a, 2012; Becker & Barkley, 2018; Becker et al., 2016; Garner et al., 2010;
Leikauf & Solanto, 2017; Lunsford-Avery et al., 2018; Wåhlstedt & Bohlin, 2010).
Nonetheless, this finding is consistent with prior research demonstrating inattentive,
hyperactive/impulsive, and SCT symptoms are unique from one another and represent
unique symptom domains that frequently occur together (Bauermeister et al., 2012;
Becker, Marshall, & McBurnett, 2014; Neeper & Lahey, 1986).
Interpretations and Implications
Differences in Internalizing Symptoms Between Diagnostic Groups
The current study explored the differences in internalizing symptoms; such as
anxiety, depression, affect regulation, and neuroticism; between individuals with varying
levels of ADHD and SCT symptomatology. The results of the analyses were partially
consistent with the first hypothesis’ prediction that there would be a significant difference
between subjects across the diagnostic groups, with those diagnosed with ADHD + SCT
having higher levels of internalizing symptoms than the other diagnostic groups. The first
hypothesis was not supported, in that individuals who exhibited clinical levels of both
ADHD and SCT symptomatology only differed from one other group on one measure of
internalizing symptoms in this study. Those with both clinical ADHD and SCT
symptomatology did not report higher levels of depression than subjects with other
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presentations of ADHD and SCT. Depression was operationalized as scores on the BDIII. Although the original post hoc comparison was significant, the use of more robust post
hoc tests found the differences between diagnostic groups’ depression levels were not
significant, but did approach significance. This is inconsistent with many previous studies
that found relationships between SCT symptoms and depressive symptoms after
controlling for ADHD symptoms. Furthermore, previous studies show individuals with
higher levels of SCT exhibit more depressive symptoms than those with lower levels of
SCT (Becker & Barkley, 2018; Bauermeister et al., 2012; Carlson & Mann, 2002;
Kamradt et al., 2018; Leikauf & Solanto, 2017). However, in the exploratory MANOVA
including both relevant internalizing symptoms and cognitive functioning, the ADHD +
SCT subjects were found to have higher levels of depression, than those with ADHD and
subclinical or negligent levels of SCT.
Subjects with ADHD + SCT did not endorse greater frequency and intensity of
anxiety than the other diagnostic groups. Anxiety was operationalized as scores on the
PSWQ. Again, although the original post hoc comparison of diagnostic groups’ anxiety
levels was significant, the use of robust post hoc tests found the between groups
differences were not significant. This is inconsistent with previous research findings that
higher levels of SCT are associated with greater intensity and frequency of anxiety
symptoms (Bauermeister et al., 2012; Carlson & Mann, 2002; Kamradt et al., 2018;
Leikauf & Solanto, 2017). The exploratory MANOVA including relevant internalizing
symptoms and cognitive functioning found the ADHD + SCT subjects reported higher
levels of anxiety than those with ADHD and subclinical or negligent levels of SCT
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The subjects’ ability to manage affect and emotion that could interfere with work
was also investigated and was operationalized as scores on the affect scale of the
BADDS. Subjects with both ADHD + SCT evidenced greater difficulty with affect
regulation than those with ADHD + subclinical SCT. Affect regulation did not
significantly differ between ADHD + SCT and ADHD-only subjects. However, in the
exploratory MANOVA including both relevant internalizing symptoms and cognitive
functioning, the ADHD + SCT subjects were found to have greater difficulty with affect
regulation than the ADHD-only subjects. This change in significance occurred despite the
difference in mean scores between these two groups remaining constant between the two
analyses.
These findings imply that the SCT symptomatology may be related to challenges
with depression, anxiety, and affect regulation in adults with ADHD. One possible
explanation for this relationship is the similarity between the symptoms investigated.
Theories attempting to explain the close relationship between anxiety, depression, and
SCT posits these constructs share several core features common to internalizing
disorders, such as apathy, rumination, daydreaming, inactivity, and decreased effort
(Smith & Langberg, 2017).
There are also similarities in the symptoms investigated by the measures used to
operationalize SCT and depression. Both the SCT scale of the BAARS-IV and the BDI-II
have items pertaining to loss of energy, fatigue, and difficulty concentrating (Barkley,
2011a; Beck et al., 1996). A number of studies have demonstrated that SCT is a distinct
syndrome from ADHD and internalizing disorders (Barkley, 2011a, 2012; Becker et al.,
2016; Garner et al., 2010; Wåhlstedt & Bohlin, 2010). The findings of this study lend
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credence to the theory that the strong relationship between internalizing symptoms and
SCT may be attributable to a common etiology, rather than a simple overlap in nosology.
Neuroticism, as measured by the NEO-PI-R, was not found to be meaningfully
related to diagnostic group membership or SCT symptomatology in the analyses
conducted. This contrasts with previous studies that have found relationships between
neuroticism, ADHD symptomatology, and SCT (Becker et al., 2018; Serine, 2016).
Neuroticism has been found to be a common element among internalizing disorders, and
has demonstrated significant correlations with internalizing symptoms (Griffith et al.,
2010). The univariate ANOVAs that found the nonsignificant effects of diagnostic group
on neuroticism were very underpowered in both the planned MANOVA (α = .01, 1-β =
.068) and exploratory MANOVA (α = .05, 1-β = .225). This decreased the likelihood that
a true effect could be detected, if one was present.
Differences in Cognitive Functioning Between Diagnostic Groups
The current study explored the differences in cognitive functioning, utilizing
measures of cognitive processing speed, auditory working memory, and deficits in
executive functioning. Interestingly, subjects’ scores on the measures of cognitive
functioning used in the MANOVA were not correlated with one another, so the analysis
could not be interpreted. Contrary to the second hypothesis, neither subjects’ auditory
working memory nor their cognitive processing speed abilities were meaningfully related
to SCT symptomatology or diagnostic group across these analyses. This contrasts with
previous research that has found low to moderate effect sizes when examining the
relationship between subtests measuring working memory and processing speed from the
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WAIS and ADHD or SCT symptomatology (Hervy et al., 2004; Jacobson et al., 2018;
Wechsler, 2008).
The lack of significant correlations may be attributable to the variety in constructs
operationalized by the measures. Although processing speed, auditory working memory,
and executive functioning are all meaningful pieces of an individual’s cognitive abilities,
they may be too disparate from one another to be conceptualized as parts of a similar
group of cognitive functions. Similar issues have arisen in past research that used loosely
related aspects of cognitive functioning to create a new composite score for use in
statistical analysis (Bauermeister et al., 2012).
Slow or “sluggish” processing speed is considered a key characteristic feature of
SCT (Becker & Barkley, 2018). The lack of significant relationships between subjects’
SCT symptoms and their performance on the Coding task of the WAIS-IV in this study
was unexpected. Previous research has found limited utility in using neuropsychological
measures of processing speed or working memory in diagnosing ADHD and SCT.
Diffuse deficits across multiple neuropsychological and cognitive domains in this
population may lead to inconsistent findings across studies examining this population
(Barkley, 2019; Hervey et al., 2004; Mapou, 2019). The false negative rate of most
neuropsychological measures is too high to be used as diagnostic measures for ADHD
(Barkley, 2019; Matier-Sharma et al., 1995; Ramsay, 2015). Perhaps these limitations are
also true for using neuropsychological measures to diagnose and measure the symptoms
of SCT.
Recent research found preliminary support for the idea that SCT symptoms in
adolescents are more clearly associated with measures of processing speed as the motor
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demands of the measure increase. Measures of processing speed that have high motor
demands, such as the grooved pegboard test, evince stronger relationships with SCT,
whereas test with moderate to low motor demands, such as the Coding task, exhibit
weaker and inconsistent relationships with SCT (Becker et al., 2020). Another study
found many commonly used measures of processing speed also require an individual to
tap into executive functioning abilities such as goal maintenance or decision making.
These unintentional demands from the measure cause executive functioning abilities to
contribute to the subject’s performance on the measure. These additional test demands
could potentially taint the operationalization of processing speed in research utilizing
these measures and may have resulted in an over estimation of processing speed’s
relationships with other constructs in prior research (Cepeda et al.,, 2013).
Use of these measures may have contributed to the variation in significance and
effect size in research examining SCT, ADHD, and processing speed, because the
measures of processing speed utilized may be tapping into an unrelated constructs such as
motor control, or constructs highly related to ADHD and SCT symptoms such as
executive functioning. Future research would benefit from identification and utilization
of measures that are relatively pure measures of processing speed. These would
demonstrate good convergent validity with other measures of processing speed as well as
discriminant validity from adjacent cognitive abilities like executive functioning.
Clinically, neuropsychological measures provide valuable information on
cognitive deficits, and are useful for identifying targets for intervention and treatment
planning, but may not be ideal for examining the deficits in individuals with ADHD or
SCT in research settings (Mapou, 2019). Clinicians and researchers advocate for more
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ecologically valid tools with better predictive power for identifying the difficulties in
cognitive functioning those with ADHD and SCT face. These include clinical interviews
or self-report measures of executive functioning, such as the BDEFS utilized in this study
(Barkley 2011b, 2019; Barkley & Fischer, 2011; Pettersson et al., 2018).
Executive dysfunction, operationalized as the BDEFS Summary score, was
strongly associated with SCT symptomatology but varied between diagnostic groups. In
fact, both the exploratory ANOVA and exploratory MANOVA found that BDEFS
Summary scores significantly varied between diagnostic groups. Specifically, the
ADHD + SCT group exhibited greater deficits in executive functioning than the ADHD +
subclinical SCT and ADHD-only groups. Executive functioning did not significantly
differ between the ADHD + subclinical SCT and ADHD-only groups. Although not part
of the planned analyses testing the hypotheses for this study, these findings lend some
support to the second hypothesis, that the ADHD + SCT group would exhibit
significantly more impaired cognitive functioning than other diagnostic groups. These
results are consistent with prior research findings indicating differing patterns of
executive functioning in adults with ADHD and SCT (Barkley, 2011b, 2012; Willcutt et
al., 2005).
Predicting SCT Symptoms Based on Internalizing Symptoms, Cognitive
Functioning, and ADHD Symptomatology
The regression analysis examined which co-occurring internalizing symptoms and
aspects of cognitive functioning were the most predictive of SCT in this sample.
Depression and executive functioning emerged as the only significant predictors of SCT
symptoms of the eight constructs investigated. Neither of the ADHD symptom scales
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from the CAARS measure was correlated with SCT symptomatology in this analysis.
This is partially consistent with the third hypothesis, that anxiety and deficits in executive
functioning would predict subjects’ levels of SCT after accounting for ADHD
symptomatology.
The lack of a correlation between ADHD and SCT symptoms was
unexpectedbecause SCT symptoms, operationalized as the BAARS-IV SCT subscale,
have been found to significantly correlate with inattentive symptoms, operationalized as
the CAARS, in prior studies. Moreover, SCT shares as much as 50% of its variance with
inattentive symptoms and up to 25% of its variance with hyperactive/impulsive
symptoms (Becker & Barkley, 2018; Garner et al., 2010; Leikauf & Solanto, 2017;
Wåhlstedt, & Bohlin, 2010). ADHD and SCT commonly co occur in the general
population, and individuals diagnosed with ADHD + SCT made up over half of the
subjects in this study. However, this surprising finding is consistent with prior research
conducted to validate SCT as a separate issue from ADHD. These studies demonstrated
the symptoms of SCT align with a different factor than the symptoms of ADHD
(Barkley, 2011a; Bauermeister et al., 2012; Becker, Marshall, & McBurnett, 2014;
Neeper & Lahey, 1986).
Anxiety was hypothesized to be the internalizing symptom that would have the
most influence on SCT, due to similarities between rumination and avoidance in anxiety
disorders and the daydreaming and low initiation aspects of SCT (Jacobson et al., 2018).
However depressive symptoms, operationalized as subjects’ scores on the BDI-II,
emerged as the only internalizing symptom that was a significant contributor to a
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regression model predicting SCT symptom levels (standardized beta coefficient = .215,
p = .013).
This finding is consistent with a previous study that explored the utility of adding
SCT as a predictor variable to multiple regression models attempting to predict
depression and anxiety. Adding SCT to the model reduced the predictive utility of
measures of ADHD symptoms and mental health treatment usage to nonsignificance, and
notably increased the amount of variance explained by the models (Becker, Langberg, et
al., 2014). These findings, combined with the present finding that depressive symptoms
significantly predict SCT, supports the idea that the symptoms of depression and SCT
have a reciprocal relationship, independent of their associations with ADHD
symptomatology. These findings also imply that the feelings of apathy, lethargy, and
psychomotor retardation common to depression and SCT are not merely superficially
similar, but stem from a common underlying problem or factor.
Executive functioning emerged as the strongest predictor of SCT symptoms in the
regression model (standardized beta coefficient = .403, p < .001). This was consistent
with the third hypothesis’ prediction that executive functioning would predict subjects’
levels of SCT in the analysis. Several studies have established executive functioning is a
better predictor of SCT symptoms than ADHD symptoms or internalizing symptoms,
even when controlling for the relationship between executive functioning and other
predictor variables (Flannery et al., 2016; Jarrett et al., 2017; Leikauf & Solanto, 2017).
For clinical practice, these results indicate the need for pretreatment screening for
SCT and executive dysfunction in individuals with major depressive disorder and other
mood disorders. Individuals with depression often experience symptoms that cause
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impairment in their ability to function such as anhedonia, fatigue, difficulty thinking or
concentrating, insomnia/hypersomnia, and inappropriate feelings of worthlessness or
guilt. SCT may be contributing to or maintaining these symptoms, leading to greater
impairment or interference with treatment efforts to manage depression or other mood
symptoms. Individuals experiencing depression and SCT may benefit from the
introduction of interventions that are typically used with individuals diagnosed with
ADHD. These interventions could enhance motivation, manage fatigue, and interrupt
rumination and daydreaming that occur in both SCT and depression.
The ADHD + SCT group exhibited greater levels of depression, anxiety, emotion
dysregulation, and executive dysfunction than the ADHD + subclinical SCT or ADHDonly groups in the exploratory analyses. Measures of depression and executive
dysfunction were found to be significant predictors of subjects’ SCT symptomatology,
whereas ADHD symptomatology was unrelated to SCT in this sample. This and other
studies have demonstrated that ADHD and SCT are distinct psychological constructs,
SCT is associated with internalizing symptomatology, and depression and executive
functioning play a stronger role in the presence of SCT than ADHD (Bauermeister et al.,
2012; Becker, Langberg, et al., 2014; Carlson & Mann, 2002; Flannery et al.,, 2016;
Jarrett et al., 2017; Kamradt et al., 2018; Leikauf & Solanto, 2017).
Limitations
Limitations of the data set. This study utilized an existing data set. As a result,
there were some artifacts that limited the analyses conducted and the generalizability of
conclusions drawn from them. Across the analyses in this study, there were unequal
sample sizes, violations of the assumptions of covariance, violation of the assumptions of
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equal variance, as well as skewed and leptokurtic data for some measures. These
limitations of the data may have impacted Type 1 error levels of the analyses conducted
and limited the generalizability of the findings.
The data was gathered from new clients during intake at a university-based, adult
ADHD outpatient specialty clinic in a large urban area. Individuals with clinical levels of
both ADHD and SCT symptomatology are overrepresented in the sample, whereas
individuals with SCT only are underrepresented, leading to unequal group sizes. Subjects
in the SCT-only group had one significant between-groups difference across all of the
analyses. It is possible that the very small sample size of SCT-only subjects was
insufficient to provide enough power to detect meaningful differences with other groups.
The proportion of subjects in this sample with clinical levels of SCT only was
comparable to that found in previous research. The prevalence of SCT in the adult
population is difficult to determine because of the close relationship between ADHD,
SCT, and other mental health symptomatology, as well as the status of SCT as a newly
identified and less well-defined mental health construct (Barkley, 2012; Becker &
Barkley, 2018; Lunsford-Avery & Mitchell, 2018). Barkley’s (2012) research validating
the BAARS-IV SCT subscale found that 5.8% of sampled adults endorsed five or more
symptoms on the SCT subscale, indicating clinical levels of SCT. Furthermore, of the
sample of 1,249 participants in Barkley’s study, 72 (5.76%) met criteria for SCT, with 33
(2.64%) meeting criteria for SCT but not ADHD (Barkley, 2012). Of the participants in
the present study, only 7 (4.9%) adults met criteria for SCT only. It is possible the
number of subjects with SCT only in this sample is representative of a low prevalence of
clinical levels of SCT without ADHD in the adult population.
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The imbalance in group sizes and negligible number of SCT-only subjects may
also be attributable to sampling bias for the clinic where the data were collected. New
clients who present for an intake at the outpatient specialty treatment clinic are likely
pursuing treatment for ADHD symptoms and co-occurring disorders. ADHD and SCT
frequently co-occur. Although seeking treatment for SCT symptoms at an ADHD
specialty clinic seems natural for those well versed in neurodevelopmental disorders or
executive dysfunction, a layperson who is experiencing only the symptoms of SCT may
not identify feelings of apathy, mental fogginess, and slow processing speed as a
developmental disorder related to ADHD. This would reduce the likelihood that they
would present for treatment at an adult ADHD outpatient specialty clinic and could
potentially lead to sampling bias for individuals with higher levels of ADHD symptoms
and bias against those with SCT only.
One critique secondary data analysis research is that the conclusions drawn from
these studies are limited to the samples from which they are drawn. These findings may
not be generalizable to larger populations or may be valid only for groups adequately
represented in the sample (Barkley, 2019). Of the 143 subjects in this study, 93 identified
as male and 111 were Caucasian. Ages and education level were both normally
distributed. Subjects’ age approached positive skewness (.91), indicating many subjects
were on the younger side of the age distribution. Mean education level was 15.74 years,
with a mode of 16. Only 16 of the 143 subjects reported having a high school education
or less.
The clinic at which the data were collected is within close proximity to several
large colleges and universities. Although information about subjects’ student status was
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not retained for the data used in this analysis, the ages and education levels in the sample
may reflect a sampling bias for individuals who either attend or work for these academic
institutions. As a result, the findings of this study may better reflect symptomatology in
young Caucasian men with clinical levels of ADHD and SCT who have completed or are
currently enrolled in a college degree program, rather than the population of adults with
ADHD.
Previous research on malingering and ADHD assessment has shown that college
students may over report their ADHD symptoms for secondary gain (Sollman et al.,
2010). The use of self-report measures may have also led to underreporting of mental
health symptoms. Young adults with ADHD tend to underreport symptoms of ADHD
and other mental health disorders, due to a lack of insight about their symptoms (Barkley
et al., 2008).
Although many of the subjects had an initial diagnosis of ADHD from the intake
process, some may have received treatment for ADHD, internalizing disorders, or another
mental health issue prior to or concurrently with the evaluation. Subjects who have
benefitted from this treatment may exhibit fewer symptoms of ADHD, lower levels of
internalizing symptoms, or less impairment in executive functioning than those who have
never received treatment (Kessler et al., 2006). The data set did not contain information
on subjects’ treatment history, so there is no way to control for potential confounds.
Another limitation of this study lies in its use of the Coding task and the Digit
Span task to operationalize cognitive functioning. Although these subtests from the
WAIS-IV have established validity as measures of processing speed and auditory
working memory, the operationalization of these measures could have been improved if
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the subjects had been administered all of the subtests from the standard WAIS-IV battery.
This would have allowed the study to utilize the PSI and working memory index (WMI).
The WMI and PSI are each calculated from three different WAIS-IV subtests, whereas
only two relevant subtests were administered as part of the diagnostic battery at the
university-based, adult ADHD outpatient specialty clinic. Therefore, this study was only
able to utilize only one subtest from the WMI and one from the PSI as opposed to three
from each.
Limitations of the analyses. In the MANOVA testing hypothesis 1 and in the
exploratory MANOVA, Levene’s test indicated the variance was unequal between the
four diagnostic groups on their BDI-II, PSWQ, Digit Span, and BDEFS Summary scores.
Because the size of the diagnostic groups was unequal and there was heterogeneity in the
variance of the groups, the accuracy of the F ratio may have been impacted, leading to
altered Type 1 error rates. Robust post hoc ANOVAs using the Brown-Forsythe statistic
caused the between groups differences on the BDI-II and PSWQ to decrease from
statistical significance to approaching significance only.
Follow-up discriminant analyses to the first MANOVA utilizing ANOVAs were
slightly under the desired power level of .80 for subjects’ scores on the BDI-II (1-β =
.751), PSWQ (1-β = .670), and BADDS-Affect (1-β =.715). NEO-neuroticism was very
underpowered in this analysis (1-β =.068). Discriminant analyses to the exploratory
MANOVA utilizing ANOVAs were underpowered for the Digit Span task (1-β = .138)
and again for NEO-neuroticism, (1-β = .225). These underpowered analyses may have
led to increased Type II error rates and could have contributed to the nonsignificant
findings for these specific analyses (Field, 2013).
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Several variables used in the analyses demonstrated troublesome levels of skew
and kurtosis. Subjects’ SCT Percentile Ranks were found to be negatively skewed
(-2.317) and leptokurtic (6.939). BDEFS Summary scores were positively skewed (3.128)
and leptokurtic (12.022). CAARS Inattentive symptom scores were negligibly negatively
skewed (-2.054) and leptokurtic (6.847). Although skewed and leptokurtic scores on
measures of SCT, ADHD, and executive dysfunction would be expected in a clinical
sample of individuals diagnosed with ADHD and SCT, these abnormal distributions
violated the assumption of normalcy of the data.
Due to unequal sample sizes, groups differing along more than one variate, and
violations of normalcy of the data, Pillai’s trace was used as the significance statistic for
the MANOVAs because it is more robust than the other statistics to violations of model
assumptions (Olson, 1974; Field, 2013). The Games Howell statistic and Brown-Forsythe
statistic were used for post hoc comparisons of groups because they are more robust
statistics when the assumption of homogeneity of covariance is violated. Although steps
were taken to accommodate violations of normalcy in these analyses, findings should be
interpreted with caution. These test statistics are robust to violations of test and data
assumptions, but not immune to error or bias.
Future Directions
More research is needed to examine how SCT relates to ADHD in various
populations of adults. Most of the studies reviewed were conducted on schoolchildren or
undergraduate students. Few studies have examined measures of SCT in adult
populations or in clinical settings (Lunsford-Avery, 2018). This study was also limited by
an overrepresentation of individuals with 16 years or more of education, Caucasians, and
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males. Future research into SCT should utilize both clinical and nonclinical samples from
a variety of adult populations, including samples from community-based mental health
clinics to access more diversity in participant demographics. Presentations of SCT in
undersampled populations, such as ethnic and cultural minority groups or individuals
with learning disabilities, should be explored to determine if SCT is overrepresented or
underrepresented in these groups.
The use of exisiting data for these analyses resulted in unequal sizes in diagnostic
groups and a dearth of subjects with SCT only. Future studies would benefit from
recruiting and individuals with the express purpose of maintaining approximately equal
diagnostic group sizes. This would potentially reduce error caused by unequal groups and
would allow for a clearer investigation of the profiles of individuals with SCT only.
A uniformly agreed-upon set of criteria to diagnose SCT does not currently exist.
By better understanding the etiology of SCT as well as the symptoms and disorders that
commonly co-occur with SCT, it would be possible to formally delineate diagnostic
criteria or identify key symptoms that can be used to diagnose and identify SCT.
Barkley found that SCT symptoms contributed the majority of the variance to
different subscales of the BDEFS. Future research could expand upon this by examining
the differences among diagnostic groups across the five subscales of the BDEFS or other
valid measures of discrete executive functions. The close relationship of SCT with
depression suggests a common underlying factor. Diagnostic groups of subjects with
varying levels of ADHD and current major depressive disorder could be compared with
ADHD-only subjects to explore the differences in SCT symptomatology. If SCT and
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depression share a common factor, such as internalization, then the groups with higher
levels of depression would have higher scores on an SCT measure.
In sum, these findings contribute to the research on the etiology and co-occurring
mental health symptoms in adults with ADHD and SCT. This study’s findings indicate
internalizing symptoms and executive dysfunction are greater in those with clinically
significant levels of ADHD and SCT. SCT, depression, and executive dysfunction had
closer relationships to one another than ADHD symptoms in a sample of adults
diagnosed with ADHD. Perhaps SCT symptomatology reflects a place in psychological
pathology where “the boundaries between disorders are more porous than originally
perceived” (American Psychiatric Association, 2013, p. 6).
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Appendix
Post Hoc Comparisons of Diagnostic Groups Using the Games-Howell Test
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